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ZUSAMMENFASSUNG 
Das  Enzym Topoisomerase I (TopI) baut durch Relaxation torsionalen Stress während der 
Replikation und der Transkription der DNS ab. Die TopI Inhibitoren Camptothecin (CPT), 
sowie seine Derivate Irinotecan und Topotecan (TPT), sind  anerkannte Chemotherapeutika. 
Die Toxizität dieser TopI- Inhibitoren wurde bisher auf die Bildung des sogenannten „TopI 
cleavage complex“ (Top1cc) auf der DNA, und die replikationsabhängige Konvertierung des 
mit dem Top1cc einhergehenden Einzelstrangbruches in einen Doppelstrangbruch (DSB) 
zurückgeführt. Neuere Untersuchungen haben aber gezeigt, dass die genannten Inhibitoren 
auch die Relaxation durch Top1 verhindern und dadurch zur Ansammlung von positivem 
„Supercoiling“, d.h. superhelikalen Windungen der DNS führen, ohne allerdings den 
Mechanismus genauer zu erklären. 
Durch biochemische und genetische Methoden und Analyse einzelner Moleküle mittels 
Mikroskopie in S. Cerevisiae, Säugerzellen und Extrakten aus Xenopus-Eiern zeigen wir,  
dass Inhibition von Top1 innerhalb kurzer Zeit Replikationsgabeln verlangsamt und deren 
„Umkehrung“ bewirkt, und dies weitgehend unabhängig von der Bildung von DSB. Poly 
(ADP-ribose) polymerase (PARP) Aktivität ist notwendig für die effektive Umkehrung der 
Replikationsgabeln und die Verhinderung von DSB, die DSB-Reparatur dagegen ist nicht 
notwendig für die Replikation und die Aktivierung der zellulären Antwort auf die Schädigung 
der DNS. Diese Ergebnisse zeigen, dass die Umkehrung von Replikationsgabeln eine 
Strategie der Zelle auf replikativen Stress ist, mit dem Ziel, Brüche der Chromosomen zu 
vermeiden, und erklärt die molekularen Grundlagen der Zytotoxizität von Top1-Inhibitoren. 
Darüber hinaus erklären unsere Daten den synergistischen Effekt von Top1 und PARP-
Inhibitoren, deren klinisches Potential in Kombinationstherapie derzeit untersucht wird. 
Als nächstes möchten wir folgende Fragen beantworten: 1) Ist die Umkehrung von 
Replikationsgabeln eine allgemeine, physiologische Reaktion auf Probleme bei der 
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Replikation? 2) Welche molekularen Mechanismen liegen dieser Umkehrung zugrunde? 3) 
Welche zellulären Faktoren sind an der Bildung, Auflösung oder Prozessierung von 
umgekehrten Replikationsgabeln beteiligt, die durch Top1-Inhibition und andere Formen von 
replikativem Stress verursacht werden? 
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SUMMARY 
Topoisomerase I (Top1) releases torsional stress during DNA replication and 
transcription and is selectively inhibited by camptothecin (CPT) and by its derivatives, 
irinotecan and topotecan (TPT), approved anticancer drugs. Top1 inhibitor cytotoxicity 
has been consistently linked to Top1 trapping on the nicked intermediate (Top1 cleavage 
complex, Top1cc) and conversion of Top1cc to toxic DSB in replicating cells. Recent 
findings showed that these drugs impair also Top1 relaxation activity, inducing 
accumulation of positive supercoiling and calling for further mechanistic insight in their 
cytotoxicity. Our single molecule, biochemical and genomic studies in S. cerevisiae, 
mammalian cells and Xenopus egg extracts show that Top1 poisons rapidly induce 
replication fork slowing and reversal, which can be largely uncoupled from DSB 
formation at clinically relevant doses. Poly (ADP-ribose) polymerase (PARP) activity is 
required for effective fork reversal and limits DSB formation, making DSB processing 
dispensable for bulk DNA replication and checkpoint activation. These data identify fork 
reversal as a cellular strategy to prevent chromosome breakage upon exogenous 
replication stress and uncover the molecular events preceding fork collapse upon Top1 
poisoning. Moreover, they provide a new mechanistic basis to explain the observed 
synergistic effects of Top1 and PARP inhibitors, under promising clinical development 
for combinatorial anticancer treatments. Ongoing and prospective experiments aim to: 1) 
elucidate whether fork reversal is a general, physiological response to replication stress, 
2) understand the molecular mechanisms leading to fork reversal, and 3) identify cellular 
factors involved in mediating, resolving or processing reversed forks upon Top1 
poisoning, as well as other kinds of DNA replication stress. 
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1. INTRODUCTION 
1.1 DNA replication 
1.1.1 General concepts of chromosome replication 
During the process of growth and division, eukaryotic cells duplicate their genomes 
with remarkable precision. The fidelity of this process depends on stringent regulatory 
mechanisms that couple DNA replication to cell cycle progression. Eukaryotic 
genomes are large, ranging from 107 to >109 base pairs (bp), and are organized into 
multiple chromosomes. Errors that result in under or over-replication of the genome 
in any cell cycle have catastrophic consequences and can result in a variety of human 
genetic diseases, including cancer, birth defects and developmental abnormalities 
(DePamphlis 2006). Many regulatory mechanisms are in place to ensure that the 
genome is replicated and then segregated equally to the resultant daughter cells. 
Sequential assembly and reorganization of complex arrays of proteins are crucial for 
the coordinated execution of initiation, elongation and termination processes of DNA 
replication. The progression of the replication fork is monitored strictly to ensure 
complete replication of the entire genome. These controls ensure that each DNA 
segment in the genome is duplicated in a timely manner exactly once per cell cycle. 
Additionally, DNA replication must be coordinated with the other events of the cell 
cycle, ensuring strict alternation of DNA replication and cell division. 
Finally, eukaryotic cells have evolved additional control mechanisms, called 
checkpoints, which limit the normal course of cell cycle progression in response to 
potentially genotoxic events, such as DNA damage or perturbations of DNA 
synthesis. These and the other regulatory mechanisms function together to maintain 
genome integrity during the replication process (Kelly and Brown, 2000). 
11
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1.1.2. Initiation of DNA replication 
In eukaryotic cells, DNA replication is initiated from multiple sites on chromosomes, 
called "origins". In Saccharomyces cerevisiae the origins exist as short, well-defined 
sequences of about 150 bp. These origins, termed as autonomously replicating 
sequences (ARS) for their ability to confer autonomous replication to plasmids, fire 
asynchronously during S-phase in order to ensure efficient replication of the 
chromosomes (Friedman et al., 1995). In the fission yeast Schizosaccharomyces 
pombe, however, the origins are more complex, lack a clear consensus sequence and 
consist of an AT-rich 500-1000 bp region (Chuang and Kelly, 1999; Kim and 
Huberman, 1998). In metazoans an even more complex picture emerges, as the 
origins of replication seem to be heterogeneous in size. In mammalian cells, 
characterization of sequence elements required for replication initiation has identified 
AT rich sequences (Paixao et al., 2004; Wang et al., 2004), dinucleotide repeats) and 
asymmetrical purine-pyrimidine sequences (Wang et al., 2004).  Other factors, like 
topology of the DNA and presence of binding sites for transcription factors, concur in 
the selection of specific segments on the genome as initiation sites for DNA 
replication (Houchens et al., 2008; Minami et al., 2006; Remus et al., 2004). 
Although the origins of replication have been difficult to define in metazoans, all 
eukaryotes utilize similar proteins and a conserved mechanism to drive initiation of 
DNA replication. DNA synthesis is initiated by the binding of initiator proteins to the 
origins of replication. In S. cerevisiae a multi-subunit protein called the origin 
recognition complex (ORC) binds specifically to ARS sequences (Bell and Stillman, 
1992)(Fig.1.1). This complex consists of six proteins, Orc1-Orc6. Similar multi-
subunit complexes have been identified in S. pombe, Xenopus and Drosophila 
melanogaster (Chesnokov et al., 1999; Gavin et al., 1995; Moon et al., 1999; Tugal et 
12
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al., 1998). In S. cerevisiae, the ORC complex is bound to origins in all stages of the 
cell cycle (Diffley et al., 1994; Liang and Stillman, 1997) and forms the core of the 
origin complex to which other components are loaded in a step-wise manner.  
The next step in the process is to load the MCM helicase on to the origin. This is 
brought about by at least two proteins, Cdc6 and Cdt1. This process is like a "clamp 
loading" procedure in which a clamp loader loads a ring shaped molecule onto the 
DNA by opening the ring. Cdc6 is an AAA+-ATPase, which is required to load the 
MCM helicase in G1 phase  and has been proposed to act as a clamp loader (Randell 
et al., 2006). Cdt1, like Cdc6 is also required to load the MCM helicase during G1 
phase in eukaryotes. The Cdc6 ATPase activity has been shown to be required for 
binding of Cdt1 to the origins in vitro (Randell et al., 2006). Hence it has been 
proposed that Cdt1-MCM complex is loaded onto the ORC-Cdc6 complex during the 
initiation step. The assembly of these four factors is known altogether as the "pre-
replicative complex" (pre-RC)(Fig.1.1). 
The transition from G1 to S phase requires the conversion of pre-RCs into active 
replication forks. Initiation requires origin unwinding, stabilization of single stranded 
DNA, and loading of the replicative polymerases. These processes need the function 
of a second set of replication factors and the activities of at least two kinases – Cyclin 
dependent kinases (CDKs and) the Dbf4 dependent kinase (DDK). Unlike pre-RCs, 
which form at early and late origins simultaneously, these factors are temporally 
regulated throughout S phase, being associated with origins at the time of activation. 
Therefore, mechanisms influencing origin choice and timing probably regulate the 
targeting of these factors to origins (Takeda and Dutta, 2005). 
Origin licensing is blocked during S, G2 and M phases of the cell cycle to prevent 
rereplication by many redundant levels of regulation. The CDKs mediate most of 
13
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these regulations. These include degradation or relocalization of the components of 
the pre-RC. For example, in yeast Cdc6 is degraded, while in mammals Cdc6 is 
exported from the nucleus after CDK phosphorylation (Delmolino et al., 2001; Drury 
et al., 2000). Another level of regulation to prevent rereplication takes place via 
Geminin. This factor has been shown to bind and inhibit Cdt1, which in turn prevents 
replication licensing by preventing the loading of MCM helicase to the origins 
(McGarry and Kirschner, 1998; Wohlschlegel et al., 2000). 
 
Fig.1.1. Model for the formation of the Pre-Replicative complex (preRC). Modified from Takeda 
and Dutta, 2005 
 
1.1.3 Origin activation and chain elongation. 
Upon initiation, The MCM complex moves away from the origins as part of the 
replication machinery. Data suggests that the MCM2-7 complex is a ring shaped 
hexameric complex and could be the putative replicative helicase (Masai et al., 2010). 
All 6 members of the gene family are essential in both budding and fission yeast. 
They are AAA+ ATPases with similarity to DNA helicases.  The MCM proteins form 
several stable sub complexes. Characterization of the MCM4-6-7 subcomplex 
revealed it has ATPase and helicase activities. The helicase activity of this complex 
was also enhanced by the presence of T-rich regions on the DNA, which is found near 
replication origins (Masai et al., 2006).  A recent study has shown that the MCM2-7 
complex is loaded onto the DNA as double hexamer and DNA runs through a central 
channel in the double hexamer (Remus et al., 2009).  
There are several hypothetical models on the mechanism by which the MCM helicase 
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separates the nascent DNA strands to allow DNA replication. In one of the models 
known as the "ploughshare model", the MCM double hexamer is loaded onto the 
origin (Fig.1.2A). After activation, single hexamers translocate in opposite directions 
along the dsDNA with a ploughshare protein helping to keep the ssDNA unwound as 
it emerges from behind the helicase (Takahashi et al., 2005). Another model known as 
“pump-in-ring” or steric exclusion model (Kaplan et al., 2003), suggests that each 
hexamer also moves bidirectionally on the DNA, but displaces the opposite strand due 
to the steric hindrance from meeting the dsDNA at the fork (Fig.1.2B). Finally, the 
“rotary pump” model has different hexamers twisting the DNA at a distance from the 
origin, resulting in topological strain and unwinding in the center (Laskey and 
Madine, 2003) (Fig.1.2C). The latter model is based on data showing that MCM2–7 
proteins are not located at replication foci in the nucleus (Madine et al., 1995). 
                            
Fig.1.2. Hypothetical models suggested for the unwinding of DNA by MCM helicase: (A) Pump 
in ring model; (B) Ploughshare model; (C) Rotary pump model. Modified from Sclafani and 
Holzen, 2007 
 
The transition from pre-RC to replication fork complex requires CDK and DDK 
activity. These kinases promote the binding of other factors like Cdc45, GINS, Sld3, 
Sld2 and Dpb11 to replication origins, all of which are essential for origin firing. 
Firstly, along with CDK and DDK activity, Mcm10 loading is required for the 
recruitment of Cdc45 (Gregan et al., 2003; Sawyer et al., 2004). Cdc45 recruitment is 
essential for the subsequent origin unwinding (Masuda et al., 2003; Mimura et al., 
2000; Walter and Newport, 2000) and loading of the replicative polymerases (Mimura 
15
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and Takisawa, 1998; Uchiyama et al., 2001; Zou and Stillman, 2000). Secondly, 
Mcm10 facilitates DDK phosphorylation of Mcm2–7 by physically interacting with 
both complexes (Lee et al., 2003). Mcm10’s function in elongation may be related to 
its ability to retain Cdc45 on elongating forks. Mcm10 also interacts with the 
elongation factors DNA polymerase δ, DNA polymerase ε and DNA2 (Kawasaki et 
al., 2000), and has been shown to activate the primase activity of DNA polymerase α 
in vitro (Fien et al., 2004). Elongating forks pause at unfired pre-RCs in a Mcm10 
mutant in S. cerevisiae (Homesley et al., 2000), suggesting that assembled pre-RCs 
may present a barrier to fork progression that is overcome though the action of 
Mcm10. 
In budding yeast, Sld2 and Sld3, which are targeted for phosphorylation by Cdc45, 
are required for origin firing. Sld3 is essential for the interaction between the MCM 
complex and Cdc45 (Kamimura et al., 2001)(Fig.1.3). It has also been shown to be 
targeted by the checkpoint to prevent late origin firing in yeast during replication 
stress (Zegerman and Diffley, 2010). Another important factor known to be associated 
with the replisome is the GINS complex. This is a stable, four-factor complex 
comprising Sld5, Psf1, Psf2 and Psf3, which is essential for DNA replication in both 
yeast and Xenopus egg extracts (Kubota et al., 2003; Takayama et al., 2003). GINS is 
necessary for the engagement of Cdc45 with the nascent replisome (Fig.1.3). It is also 
required for continued association between Cdc45 and MCM complex during S-phase 
progression (Kanemaki and Labib, 2006; Labib and Gambus, 2007). The GINS 
complex may be involved in coordinating the progression of the MCM helicase and 
priming events at the replication fork (Marinsek et al., 2006). 
The replisome is assumed to comprise not only factors essential for replication, but 
also factors involved in other chromosome transactions and chromatin regulation. 
16
_____________________________________________________________
                           INTRODUCTION
_____________________________
These are referred to as "replisome progression complexes" (RPC), which are 
composed of more than 20 replication related proteins (Gambus et al., 2006). In 
addition to Cdc45, MCM complex and GINS (referred to as the CMG complex), The 
RPC contains MRC1, Tof1 and Csm3 (Claspin, Timeless and Tipin in mammalian 
cells), that are considered fork stabilization factors (Calzada et al., 2005).  
 
Fig.1.3.  Model for the activation of pre-RC by the recruitment of the proteins composing the 
Replisome Progression Complex (RPC) . Modified from Takeda and Dutta, 2005 
 
Once the duplex DNA at the origin is unwound by the MCM helicase, replication on 
both the leading and the lagging strands is initiated. Since DNA consists of anti-
parallel strands, DNA polymerases must use a 3'-OH of a nucleoside as a primer and 
synthesize DNA in the 5'-3' direction. Both strands of the DNA helix are copied 
differently, with one strand synthesized continuously (leading strand) and the opposite 
strand copied in short - approximately 200 bp - segments (Okazaki fragments), which 
are joined together postreplicatively (lagging strand). Both the leading strand and 
every Okazaki fragment on the lagging strand are primed by a short RNA that is 
synthesized de novo by a specialized RNA polymerase called primase, which in 
eukaryotes is part of the Pol α polymerase complex, known as Pol α–primase 
(Stillman, 2008). This tetrameric complex comprises two subunits of Pol α together 
with two primase subunits. Primase acts by synthesizing a short (approx. 10 nt) RNA 
17
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primer. The 3' end of the nascent strand then translocates from the primase active site 
to the polymerase active site to allow synthesis of about 20 nucleotides of DNA 
(Fig.1.4). After this initiation event, the clamp loader complex replication factor C 
(RFC) loads the sliding clamp and processivity factor PCNA onto double-stranded 
DNA (Garg and Burgers, 2005). Either Pol δ or Pol ε is then loaded on to the PCNA–
primer– template ternary complex. The sliding clamp encircles the double-stranded 
DNA and tethers Pol δ and Pol ε to the template to increase enzyme processivity, 
although the mechanism by which this occurs is not clear. Pol ε has been shown to be 
the polymerase responsible for leading strand synthesis (Pursell et al., 2007)(Fig.1.4). 
It is a highly processive enzyme. Lagging strand synthesis on the other hand requires 
Pol δ (Fig.1.4). It is thought to proceed in several discrete stages, i.e., initiation by 
DNA primase, limited elongation of the RNA primer by Pol α, a switch of the primer 
terminus from Pol α to Pol δ proposed to be brought about by RFC, elongation by Pol 
δ, and maturation of the completed Okazaki fragment in conjunction with Fen1 and 
DNA ligase1. Each transition is believed to be mediated by a specific protein or 
protein complex and has to occur with very high efficiency (Garg and Burgers, 2005). 
                                       
 Fig.1.4. Model of a eukaryotic replication fork, depicting the main factors involved in DNA 
synthesis. Modified from McCulloch and Kunkel, 2008 
 
Unwinding of the DNA helix during replication by the replicative helicase leads to the 
generation of topological stress in the form of supercoiling on the DNA, which needs 
18
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to be resolved for proper fork progression. DNA topoisomerases are enzymes that 
control and modify the topological state of DNA. By transiently breaking a DNA 
strand and passing another strand through the transient break (type I topoisomerases), 
or by transiently breaking a pair of complementary strands and passing another 
double-stranded segment (type II topoisomerases), these enzymes can catalyze many 
types of interconversions between DNA topological isomers (topoisomers) (Wang, 
2002). 
Topoisomerase 1 (Top1) tends to be concentrated in supercoiled regions of chromatin, 
mostly associated with ongoing transcription or replication (Wang, 2002). It has been 
shown that Top1 encircles the DNA tightly like a clamp (Stewart et al., 1998) and 
creates a nick. The relaxation of the supercoils takes place in a stepwise manner 
which does not allow free rotation of the DNA. It is brought about by a swivel 
mechanism which involves friction between the rotating DNA and the enzyme cavity 
and controls the speed of rotation (Koster et al., 2005). Once the relaxation is 
achieved, the DNA is religated back by Top1 activity in a manner that requires 
reversing its covalent binding. The religation step requires the 5'-OH group at the 
DNA end to be aligned with the tyrosine DNA phosphodiester bond which is formed 
between a tyrosine in the active site of Top1 and DNA during the nicking reaction. 
Under normal conditions, the cleavage intermediates are transient and religation is 
favored over cleavage (Pommier, 2006)(Fig.1.5). A recent study showed that deletion 
of Top1 in human and yeast cells results in slow progression of the replication forks 
and formation of double stranded breaks (DSB) upon collision of the replication and 
the transcription machinery (Tuduri et al., 2009). Topoisomerase 1 is a target for 
chemotherapeutics of the class of camptothecins, the details of which will be 
discussed later in this Introduction. 
19
_____________________________________________________________
                           INTRODUCTION
_____________________________
                  
Fig. 1.5. A model for the mechanism of Topoisomerase1 action. Modified from Pommier,2006 
 
1.1.3 Termination of DNA replication 
Termination of replication occurs when two opposing replication forks meet and the 
nascent DNA from the two forks is ligated together. In prokaryotes, which have 
circular chromosomes as genetic material, termination occurs at sequence specific 
termini called Ter sites. Such sites (also known as Replication fork barriers or 
replication termination sites) are also present in specific regions of the eukaryotic 
chromosomes like the non-transcribed spacers of ribosomal DNA from yeast to man 
(Rothstein et al., 2000). These replication fork barriers (RFB) are specific DNA 
sequences that arrest further progress of a replication fork. In these specific regions, 
termination is achieved by arresting the first fork that enters the termination region, 
20
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forcing it to wait there for the inevitable collision with the fork coming from the 
opposite direction. The best-characterized blocks to eukaryotic replication due to 
RFBs is the ribosomal DNA repeats of budding yeast on chromosome XII. The RFB 
is bound by a protein called Fob1 (Brewer et al., 1992; Linskens and Huberman, 
1988; Mohanty and Bastia, 2004), but the mechanism by which Fob1 prevents  
replication fork progression is still elusive. It 
is thought  that the Fob1-RFB complex 
inhibits the passage of the replicative MCM 
helicase thus stalling the fork,  allowing the 
fork from the other direction to come in 
terminate. A recent study in yeast has 
identified and characterized 71 chromosomal 
termination regions (TER) in budding yeast.  
Interestingly, almost all the TERs were shown 
to contain pausing elements, such as 
transcription clusters   or   centromeric   
regions, that determine the position of fork 
merging, thus suggesting pausing of the   1st  
fork     as a     general     mechanism    for  
replication termination. Furthermore, the  
 
 
 
Fig.1.6. Model for replication fork termination  
Modified from Fachinetti et al., 2010 
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DNA helicase Rrm3 was shown to assist fork progression across TERs. Top2 was 
also shown to bind TERs during S-phase and G2/M to facilitate fork fusion and 
prevent DNA breakage (Fachinetti et al., 2010)(Fig.1.6).  
22
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1.2 DNA damage and repair mechanisms. 
1.2.1. DNA damage and consequences. 
Cell survival depends on the faithful and accurate transmission of genetic information 
during cell division. To reach this goal, cells require not only high fidelity DNA 
replication and precision in chromosome segregation, but also the ability to survive  
both environmental and endogenous sources of damage which cause a number of 
different types of lesions on the DNA.   Alkylating and oxidizing agents, UV, and 
ionizing radiation, are among the agents that can result in such lesions. 
If these lesions are converted in mutations - either by means of faulty repair or 
replication errors - the changes are permanent and have their effects in the daughter 
cells. One of the possible outcomes of mutations is the loss of tumor-suppressor genes 
and the improper activation of oncogenes, which trigger uncontrolled cellular 
proliferation and the development of malignant cells. Indeed, genome instability is the 
hallmark of all forms of cancer (Bartek and Lukas, 2007). Besides these permanent 
changes to DNA sequence, the epigenome (modifications of DNA bases and of 
associated histones) can also be subjected to time-dependent, semi-permanent 
changes; growing evidence suggests that epigenetic changes significantly contribute 
to cancer (Esteller, 2007). 
DNA integrity is compromised mainly from three sides. 1) Spontaneous reactions 
(mostly hydrolysis) intrinsic to the chemical nature of DNA in an aqueous solution 
create abasic sites and cause deamination (Lindahl, 1993). 2) Cellular metabolism 
generates reactive oxygen and nitrogen species, lipid peroxidation products, 
endogenous alkylating agents, estrogen and cholesterol metabolites, and reactive 
carbonyl species (De Bont R, 2004), all of which potentially damage DNA. Reactive 
oxygen and nitrogen species alone generate several kinds of single-strand breaks and 
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more than 70 oxidated base and sugar products in DNA. 3) DNA is damaged by 
exogenous physical and chemical agents like UV and carcinogens present in different 
chemicals. DNA in a cell can be exposed to up to 104 endogenous lesions per day 
(Lindahl, 1993). A single day in the sun can induce up to 105 UV photo- products in 
each exposed keratinocyte, and inflammation can cause high levels of oxidative 
damage locally (Hoeijmakers, 2009). 
                                  	  
Fig.1.7. Model depicting the sources and the consequences of DNA damage. Modifed from 
Hoijemakers, 2009 
 
Different types of DNA injury can induce mutations that may finally result in cancer, 
cell death or senescence, and may also contribute to aging (Fig.1.7). Some lesions are 
primarily mutagenic, others mainly cytotoxic or cytostatic. Many DNA lesions lead to 
both types of outcomes in different ratios, depending on the location and number of 
lesions, cell type, and stage in the cell cycle and differentiation. For example, a well-
known mutagenic injury is 8-oxoguanine, an oxidative lesion that on DNA replication 
pairs equally well with the cytosine (normal pairing) and adenine (abnormal pairing), 
causing GC→TA transversions (Akbari and Krokan, 2008). In contrast, double strand 
breaks that are induced by ionizing radiation or that occur during the processing of 
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interstrand cross-links are primarily cytotoxic or cytostatic.  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   
1.2.2 DNA damage repair mechanisms 
To cope with damages in the genetic material, evolution has endowed cells with an 
array of DNA repair pathways (Fig.1.8). These include systems that repair or replace 
damaged bases, restore the integrity of the DNA backbone, and allow tolerance of 
DNA damage. Furthermore, cells have the possibility to activate checkpoints that 
arrest or attenuate cell cycle progression to allow for repair to take place. 
Characteristic features of the main DNA repair pathways will be briefly discussed in 
this chapter. 
                      
Fig.1.8. Schematics on different DNA damage sources and repair mechanisms. Modified from 
Hoijemakers 2001. 
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 1.2.2.1 Base Excision Repair 
Base excision repair is the primary pathway responsible for the repair of DNA  bases 
from a variety of damage that arise due to oxidation, alkylation, deamination and 
depurination/depyrimidination. BER repairs the damaged DNA by two general 
pathways: short patch and long patch BER. The short patch repair pathway is used to 
repair a single damaged nucleotide, whereas the long patch pathway is used in the 
repair process of at least two nucleotides. (Robertson et al., 2009). The core BER 
repair pathway requires the function of at least four proteins which include a DNA 
glycosylase, an AP endonuclease or AP DNA lyase, a DNA polymerase and a DNA 
ligase (Kubota et al., 1996).  The first step in BER is the recognition of the damaged 
base by a DNA glycosylase which catalyses the cleavage of an N-glycosidic bond, 
removing the damaged base and creating an apurinic or apyrimidinic site (AP 
site)(Fig.1.9).  In addition to catalyzing the cleavage of N-glycosidic bonds, some 
glycosylases are bifunctional having additional AP lyase activity (O'Connor et al., 
1989). 11 different mammalian glycosylases have been characterized so far 
(Robertson et al., 2009). One of the glycosylases, OGG1, can effectively catalyze the 
cleavage of an N-glycosidic bond between a deoxyribose sugar and the damaged base 
8-oxoguanine (8-oxoG), which results from the oxidative damage of a guanosine 
base. 8-oxoG can base pair with adenine as well as cytosine resulting in G- to -T 
transversion mutation. 
The next step in the process is the cleavage of the DNA backbone by an AP 
endonuclease or a DNA AP lyase - the activity of which might be present in some 
glycosylases. There are two different activities capable of cleaving DNA at the AP 
site. The AP nuclease activity incises the DNA 5'to the AP site creating a sugar 
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moiety, which must be processed by a DNA polymerase to allow DNA ligation 
(Fig.1.9). Alternatively, an AP lyase activity in combination with a glycosylase 
creates a DNA nick containing a 3' sugar moiety, which requires further processing by 
a polymerase to provide a suitable substrate for a DNA ligase. 
 
Fig.1.9. Model depicting the mechanism of BER. Modified from Hoijemakers, 2001. 
 
After the cleavage of the DNA backbone, a DNA polymerase fills the gap with the 
correct nucleotide. For short patch BER DNA polymerase β catalyses this reaction 
that requires XRCC1 which acts as a scaffold for the recruitment of the ligase as well 
(Kubota et al., 1996). On the other hand gap filling in Long patch BER is thought to 
require Polδ and /or Polε, which in turn requires the processivity factor PCNA for its 
activity (Frosina et al., 1996)(Fig.1.9). 
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 Finally a DNA ligase completes the repair process and restores the integrity of the 
helix by sealing the nick. The one-nucleotide short patch BER pathway is completed 
by the action of DNA ligase III (Kubota et al., 1996). Completion of the Long patch 
BER requires the activity of the replicative DNA ligase I. In addition, long patch BER 
also requires the activity of flap structure-specific endonuclease1 (Fen1) since strand 
displacement by polymerase produces a flapped substrate, which is refractory to 
ligation. Fen1 resolves this problem by removing this flapped substrate (Robertson et 
al., 2009)(Fig.1.9). 
              
1.2.2.2 Nucleotide Excision repair 
NER is involved in the removal of lesions that distort the DNA double helix, interfere 
in base pairing and block DNA replication and transcription. The most common 
among these lesions are the cyclobutane pyrimidine dimers (CPDs) and the 6-4 
photoproducts (6-4PPs), the most common injuries inflicted by ultraviolet (UV) light 
and many other kinds of adducts induced by chemical agents. Deficiency in the NER 
pathway leads to many human diseases such as Xeroderma Pigmentosum, Cockayne's 
syndrome and trichothiodystrophy (Costa et al., 2003). 
 There are two pathways for NER : 1) Transcription coupled repair (TCR), selective 
for lesions present in the transcribed strand of expressed genes and 2) the Global 
genome NER (GGR) that acts over the rest of the genome. 
The first step of NER is the recognition of the DNA lesion by the repair machinery. 
This step is considerably different for TCR and GGR. The crucial step for damage 
recognition in GGR is brought about by the XPC-hHR23B complex (Sugasawa et al., 
1998)(Fig.1.10).	   The presence of unpaired bases is a key factor for specific DNA 
binding by XPC. It poorly recognizes certain types of lesions that induce only a subtle 
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helix distortion, unless they are combined with a mismatched sequence. For instance, 
many oxidative base lesions are not highly distorting, so that they are usually detected 
and handled by base excision repair rather than NER. Another relevant example is the 
UV-induced CPD where the two affected pyrimidines continue to have a hydrogen 
bond with the opposite purines, causing minimal helix distortions and thus poor 
recognition by XPC (Kim et al., 1995). These lesions can be recognized by the UV-
DDB complex, which consists of two subunits, DDB1 and DDB2. This complex is 
thought to promote XPC recruitment to certain type of UV lesions thus facilitating 
(Sugasawa, 2010)(Fig.1.10). 
 
Fig.1.10. Model depicting the mechanism of NER. Modified from Sugasawa, 2010 
On the other hand, the XPC-hHR23B complex is dispensable for TCR. For this 
pathway, the first signal for repair activity is the blockage of transcription elongation 
by RNA polymerase II in front of DNA lesions (Costa et al., 2003)(Fig.1.10). The 
stalled polymerase must be displaced to make the injury accessible for repair (Le Page 
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et al., 2000), and this requires at least two TCR-specific factors: CSB and CSA. The 
subsequent stages of GG-NER and TCR may be identical. The XPB and XPD 
helicases of the multi-subunit transcription factor TFIIH open ~30 base pairs of DNA 
around the damage. XPA then confirms the presence of damage by probing for 
abnormal backbone structure (Buschta-Hedayat et al., 1999). If the damage is absent 
the NER process is aborted (Sugasawa et al., 2001). The single-stranded-binding 
protein RPA (replication protein A) stabilizes the open intermediate by binding to the 
undamaged strand (Fig.1.10). The use of subsequent factors, each with limited 
capacity for lesion detection, still allows very high damage specificity (Sugasawa et 
al., 1998). The XPG and ERCC1/XPF, respectively cleave (Houtsmuller et al., 1999) 
the borders of the opened stretch only in the damaged strand, generating a 24–32-base 
oligonucleotide containing the lesion. The regular DNA replication machinery then 
completes the repair by filling the gap. In total, 25 or more proteins participate in 
NER. In vivo studies indicate that the NER machinery is assembled in a step-wise 
fashion from individual components at the site of a lesion. After a single repair event 
the entire complex is disassembled (Houtsmuller et al., 1999). 
                             
1.2.2.3 Mismatch Repair 
Mismatch repair (MMR) is responsible for several genetic stabilization functions, like 
correction of DNA biosynthetic errors, ensuring the fidelity of genetic recombination, 
and participation in the earliest steps of checkpoint and apoptotic responses to several 
classes of DNA damage (Jiricny, 2006; Kunkel and Erie, 2005). Defects in this 
pathway are the cause of typical and atypical hereditary nonpolyposis colon cancer, 
but may also play a role in the development of 15–25% of sporadic tumors that occur 
in a number of tissues (Modrich, 2006). Mismatch repair-deficient tumor cells are 
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resistant to certain cytotoxic chemotherapeutic drugs (Iyer et al., 2006; Jiricny, 2006), 
a manifestation of its involvement in the DNA damage response.  
The human genome contains multiple MutS and MutL complex, heterodimeric 
proteins  complexes which are essential for MMR. The functions of the MutS and 
MutL complex are discussed in Table1.1. 
 
Table1.1. Functions of MutL and MutL complexes in MMR. Adapted from Jiricny 2006 
 
The MutSα can initiate the repair of different kinds of mismatches and 
insertions/deletions (IDLs) of up to 8 unpaired nucleotides. MutSβ is able to repair 
even larger IDLs , but cannot recognize mispairs. MutLα supports repair initiated by 
MutSα and MutSβ, whereas the other two heterodimers, MutLβ and MutLγ play only 
a secondary role in MMR.  
The repair is initiated by MutSα recognition of a mismatch. Once the complex is 
bound, a conformational change is brought about by ATP allowing the complex to 
diffuse along the DNA in both the directions. The MutSα-ATP complex along with 
MutLα, searches for a strand discontinuity (Fig.1.11). When a nick is found, 
Exonuclease1 (Exo1) degrades the DNA in a 5'-3' direction and excises the mismatch. 
The single strand binding protein RPA binds the complementary strand and protects 
the ssDNA against endonucleolytic cleavage (Jiricny, 2006). On the other hand, 
PCNA and RFC are needed for initiating the latent endonucleolytic activity of MutLα 
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if a 3' nick is found. MutLα  nicks  the DNA 5' of the mismatch, which then allows  
Exo1 mediated strand degradation in the 5'-3' direction. Finally the gap is filled by the 
action of Polδ and the nick sealed by DNA ligase I (Jiricny, 2006)(Fig.1.11). 
                                     
Fig.1.11. Model for MMR. Adapted from Jiricny, 2006 
 
1.2.2.4 Homologous Recombination Repair 
Homologous recombination (HR) constitutes a key repair and tolerance pathway for 
complex DNA damage, which includes DNA double-stranded breaks (DSB), 
interstrand crosslinks (ICL) and DNA gaps. In addition, recombination and 
replication are intimately linked, as recombination recovers stalled and broken 
replication forks. Defects in HR lead to genomic instability and elevated cancer 
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predisposition, indicating a clear cellular need for this process (Heyer et al., 2010) 
 
Fig.1.12. Model for HR. Modified from Heyer et al., 2006 
The HR process can be divided into 3 stages: presynapsis, synapsis and post synapsis 
(Fig.1.12). In presynapsis, the DNA damage is processed to form extended regions of 
single stranded DNA (ssDNA) which is bound by the ssDNA binding protein RPA. 
For DSBs in mammalian cells, this step involves 4 different nucleases - the MRN 
complex (Mre11, Rad50, NBS1), Exo1, DNA2 and CtIP (Mimitou and Symington, 
2009) - as well as the helicase activity of BLM (Fig.1.12). RPA then binds to the 
ssDNA. inhibiting formation of secondary structures, which is needed for the proper 
assembly of Rad51 filaments. RPA bound to ssDNA also forms a kinetic barrier 
against Rad51 filament assembly, making it necessary for mediator proteins to allow 
timely Rad51 filament formation on RPA-covered ssDNA. Three different classes of 
mediators have been described, but their mechanisms of action and the interplay 
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between them is poorly understood. The Rad51 paralogs constitute a first group and 
comprise five proteins in mammals (RAD51B, RAD51C, RAD51D, XRCC2, 
XRCC3). A second class is typified by the Rad52 protein, which performs two 
independent roles: its mediator function, and a second, later function in strand 
annealing of RPA-bound ssDNA (Heyer et al., 2010). A third class of mediator 
proteins is BRCA2, the human breast and ovarian cancer tumor suppressor protein. 
Human BRCA2 contains ssDNA binding motifs, a double-stranded DNA (dsDNA) 
binding motif and a number of Rad51 binding sites (Yang et al., 2005). Recent 
biochemical studies have shown that BRCA2 binds RAD51 and potentiates 
recombinational DNA repair by promoting assembly of RAD51 onto single-stranded 
DNA (ssDNA). It acts by targeting RAD51 to ssDNA over double-stranded DNA, 
enabling RAD51 to displace replication protein-A (RPA) from ssDNA and stabilizing 
RAD51–ssDNA filaments by blocking ATP hydrolysis. BRCA2 does not anneal 
ssDNA complexed with RPA, implying it does not directly function in repair 
processes that involve ssDNA annealing, but acts as a mediator protein (Jensen et al.). 
During synapsis, the Rad51 filament performs homology search and DNA-strand 
invasion, generating a displacement loop (D-loop), within which the invading strand 
primes DNA synthesis. The Rad54 motor protein is required for stabilizing the Rad51 
filament and enhancing D-loop formation by Rad51. It is also required for promoting 
the transition from DNA strand invasion to DNA synthesis by dissociating Rad51 
from heteroduplex DNA (Heyer et al., 2006). Finally, in postsynapsis, the three sub 
pathways of HR are distinguished, each with specific enzymatic requirements (Heyer 
et al., 2010)(Fig.1.12). The D-loop represents the branching point for the multiple 
sub-pathways of HR. In the absence of a second end, the D-loop may become a full-
fledged replication fork in a process termed break-induced replication (BIR). 
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Although this process restores the integrity of the chromosome, it can lead to loss-of-
heterozygosity of all genetic information distal to the DSB. In the presence of a 
second end, the predominant pathway for DSB repair in somatic cells appears to be 
synthesis-dependent strand annealing (SDSA), in which the extended D-loop is 
reversed, leading to annealing of the newly synthesized strand with the resected strand 
of the second end (Paques and Haber, 1999). This pathway inherently avoids 
crossovers, which reduces the potential for genomic rearrangements. While 
generation of crossovers by double Holliday junction (dHJ) formation is typical of 
meiotic recombination in germ cells, recently dHJs have also been identified as an 
intermediate in recombinational DNA repair in somatic cells (Bzymek et al.). dHJ 
formation involves capture of the second end, a process that is actively blocked by the 
Rad51 protein in vitro, suggesting an inherent mechanistic bias toward SDSA (Wu et 
al., 2008). The dHJ intermediate could be resolved by endonucleases like Mus81-
Eme1 or Gen1, but the exact mechanisms and identity of proteins involved remain 
under debate. Alternatively, dHJs can be dissolved by a complex mechanism 
involving a RecQ-family DNA motor protein (S. cerevisiae Sgs1 or human BLM), 
TopoisomeraseIII (Top3), and cofactors. The two junctions are migrated toward each 
other, leading to a hemicatenane that is eliminated by Top3 (Fig.1.12). Genetically, 
the end point of dissolution is always a noncrossover, avoiding the potential for 
rearrangements associated with crossovers (Wu et al., 2008). Crossovers are defined 
as recombination events that lead to the exchange of flanking markers generating 
deletions, inversions, or translocation when non-allelic, repeated DNA sequences are 
involved. 
                            
  
 
35
_____________________________________________________________
                           INTRODUCTION
_____________________________
1.2.2.5 Non Homologous End joining   
Non-homologous end joining (NHEJ) is a pathway that specifically repairs DSBs in 
DNA. NHEJ is referred to as "non-homologous" because the break ends are directly 
ligated without the need for a homologous template, in contrast to homologous 
recombination, which requires a homologous sequence to guide repair. 
Both HR and NHEJ play a role in DSB repair in mammalian cells. The most 
important factor determining the choice of repair pathway is probably the cell cycle 
stage. Whereas HR depends on the use of a template — that can be found on a sister 
chromatid during S and G2 cell cycle phase — NHEJ brings the DNA termini 
together in a protein–DNA complex and joins them without the need for homology.  
This pathway is mainly functional during G0, G1 and early S-phase (Weterings and 
van Gent, 2004). 
The first step of NHEJ is generally considered to be recognition of a DSB, which 
requires association of DNA termini with the Ku70/80 heterodimer (Fig.1.13). Once 
the Ku ring is bound to DNA ends, it facilitates recruitment to the DSB of the DNA-
dependent protein kinase catalytic subunit (DNA-PKcs). The simultaneous and 
specific binding of both Ku and DNA-PKcs to DNA ends activates the 
serine/threonine kinase activity of DNA-PKcs. This leads to phosphorylation of 
XRCC4, p53 and Artemis. DNA-PKcs also phosphorylates the Ku70, Ku80 and 
DNA-PKcs subunits of the DNA-PK holo-enzyme itself. The autophosphorylation of 
DNA-PKcs causes a conformational change in the protein that regulates access by 
other NHEJ proteins (Uematsu et al., 2007). This conformational change in DNA-
PKcs may also alter the conformation of Artemis which can function as a 5'- or 3'-
endonuclease at overhangs (Ma et al., 2002) and process DNA termini which have 
non-ligatable ends. Finally XRCC4/Ligase 4 is recruited, which promotes the 
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religation of the broken ends with the help of the stimulatory factor XLF (Mahaney et 
al., 2009) (Fig.1.13). 
 
Fig.1.13. Model depicting protein-DNA interactions during NHEJ. Modified from Budman et al., 
2007. 
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1.2.3. DNA damage tolerance mechanisms 
 
1.2.3.1 Translesion synthesis 
Although the cells have evolved elaborate repair mechanisms to counteract DNA 
damage, the repair processes are in some cases slow and incomplete. In these 
circumstances, the cell is forced to replicate DNA containing persisting damage. It is 
generally not possible for the replicative polymerases to accommodate damaged base 
in their active site due to high stringency and fidelity. For this reasons, replication 
past lesions requires the use of specialized DNA polymerases which have been 
adapted for this specific function. These polymerases have lower stringency than the 
replicative polymerase and their active sites are more open and can therefore 
accommodate damaged bases. There is a growing number of DNA polymerases 
recently found to mediate DNA synthesis across specific damages. The four main 
players of this family in human cells are polη, polι, polκ, Rev1 and Polλ. Each one is 
able to carry out TLS past different lesions in vitro. 
It has been suggested that for UV induced lesions like CPDs, translesion synthesis 
(TLS) with polη is most efficient, inserting the correct nucleotide opposite the 
damaged base (Masutani et al., 2000). In its absence, a less efficient and more error-
prone pathway is brought into play leading to UV induced hypermutations in the 
DNA.	  	  It has been shown that polη localizes to the nucleus, and that during S phase it 
accumulates in nuclear foci at sites of DNA synthesis (Kannouche et al., 2001). The 
mechanism by which polη is thought to be recruited to the replication forks upon UV 
damage is by monoubiquitination of PCNA by Rad6 and Rad18 (Kannouche et al., 
2004) which increases the affinity of PCNA for polη. This increased affinity for polη 
brings about the " polymerase switch" where polδ is replaced by polη at the damaged 
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replication fork. polη then carries out replication past the CPD. After the lesion is 
bypassed, polη dissociates and chain extension is taken over by the more processive 
polδ (Lehmann, 2005)(Fig.1. 4). 
 
Fig.1.14  Model for TLS in mammalian cells. Modified from Lehmann 2005. 
Polι on the other hand can inserts correct bases opposite different kinds of lesions 
(Tissier et al., 2000), but cannot complete the bypass thus requiring another 
polymerase to carry out TLS past different lesions. In support to ist role in TLS, it has 
also been shown to interact strongly with polη (Kannouche et al., 2003)(Fig.1.14). 
Another TLS polymerase, polκ, is able to bypass benzo[a]-pyrene (BaP)-guanine 
adducts quite efficiently and accurately and could also participate in bypass of UV 
lesions, although its molecular role has not been elucidated (Ogi et al., 2002). 
Rev1, though structurally a member of the Y-family of polymerases, is a dCMP 
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transferase, rather than a DNA polymerase. Little is known about its mechanism of 
action, but it appears to have a role in the prevention of mutagenesis after DNA 
damage (Gibbs et al., 2000). It has been shown to interact with the other TLS 
polymerases and also with Rev7 suggesting its role in TLS (Lehmann, 2005). It has 
also been speculated to act as a platform for the switch between TLS polymerases 
(Kannouche and Stary, 2003).  
Finally, Pol λ has also been implicated in the bypass of 8-oxoguanine lesions, which 
are formed on the DNA by the production of free radicals. This bypass process 
requires the presence of PCNA and Replication protein A (RPA) (Maga et al., 2007). 
 
1.2.3.2  Template switching mechanisms 
Template switching has evolved as an important mechanism to promote fork restart, 
gap-filling and damage bypass. Among damage tolerance mechanisms, template 
switching contributes largely to error-free bypass and opposes the undesirable effects 
associated with mutagenesis. The template switching pathway is mainly controlled by 
RAD5–MMS2–UBC13 genes encoding ubiquitin ligases and ubiquitin conjugating 
enzymes that mediate PCNA polyubiquitylation (Hoege et al., 2002) and is 
hypothesized to involve a switch of templates in which the blocked nascent strand 
uses the undamaged newly replicated strand of the sister chromatid as a temporary 
replication template (Xiao et al., 2000)(Fig.1.15). One of the models suggested for 
lesion bypass requires the formation of a reversed fork intermediate, without any 
requirement for recombination proteins (Higgins et al., 1976). Although the ATPase 
Rad5 can promote fork reversal in vitro (Blastyak et al., 2007; Johnson et al., 1994), 
whether the reversed fork intermediate promotes error-free bypass of lesions in vivo 
remains a matter of debate. Another mechanism of error free lesion bypass proposes a 
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recombination-like invasion event, in which the blocked nascent chain invades the 
opposite homologous duplex and uses the sister chromatid as a template (Minca and 
Kowalski)(Fig.1.15). It has been suggested that template switching behind the fork 
leads to X- shaped structures that contain ssDNA, and in which the sister chromatids 
are linked (Branzei, 2010). These template switch intermediates may also contain 
Holliday Junctions (HJs) (Mankouri et al., 2011)(Fig.1.15). Whereas the reversed fork 
model restricts these events to the fork, the recombination-like invasion mechanism 
can theoretically occur either at the fork or behind the fork. 
 
Fig.1.15 A model depicting template switch mechanisms. Modified from Branzei 2011. 
The error-free template switch bypass is controlled by the E3 ligase Rad5 that 
stimulates the E2 ubiquitin conjugating activity of the Mms2–Ubc13 complex to 
polyubiquitinilate PCNA (Hoege et al 2002). PCNA polyubiquitylation and error-free 
Rad5–Mms2–Ubc13 complex are required for gap-filling damage tolerance (Branzei 
et al 2004). They are also required for the formation of damage-dependent sister 
chromatid junctions behind replication forks (Branzei et al 2008)(Fig.1.15).  
The template switch intermediates need to be resolved in order to restore a normal 
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replication fork and chromosomal structure. Several resolvases have been identified in 
eukaryotic cells but little is known about their regulation and coordination with one 
another. Resolution of damage-induced template switch intermediates has been shown 
to require RecQ helicase Sgs1 (BLM in humans) and Topoisomerase3 (Liberi et al., 
2005; Mankouri and Hickson, 2006)suggesting that Sgs1–Top3 represents the major 
activity involved in template switch intermediate resolution. 
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1.3 Checkpoint signaling in DNA Damage. 
Cells have evolved multiple mechanisms to sense DNA lesions and signal their 
presence thus activating specific repair pathways. The DNA damage response (DDR) 
pathway is a signal transduction pathway consisting of sensors, transducers and 
effectors, which form a network of interacting pathways that together execute the 
response. The DDR results in the induction of DNA damage checkpoints. These 
checkpoints halt the proliferating cell in its cell cycle progression, providing more 
time to the DNA damage repair machinery to repair the lesion. The main players in 
the checkpoint-signaling cascade are proteins of the Phosphoinositol 3 (PI3) kinases, 
ATM and ATR. The DNA damage checkpoint can be broadly activated by two kinds 
of stress: 1) DNA double strand breaks (DSB), which is mediated by the ATM 
pathway and 2) Replication associated stress, mediated by the ATR pathway. 
Although the two types of stress response pathways are distinguished, considerable 
amount of crosstalk exists between them. 
DSB are considered the most lethal among DNA insults and can be caused by both 
intracellular and extracellular agents such as reactive oxygen radicals, ionizing 
radiation or radiomimetic drugs. DSB induce a robust DDR mechanism, which has 
been widely studied in eukaryotes. The first step in DDR is the sensing of the DSB. 
Multiple signals that arise from DSB could lead to crosstalking downstream events. 
One of these signals is chromatin decondensation, which in turn leads to ATM 
activation, chromatin association of 53BP1 which acts as a mediator and recruitment 
of Rad51 repair complex (Su, 2006)(Fig.1.16). The association of the Mre11-Rad50-
NBS1 complex to the DNA has also been implicated in DSB sensing (Lee and Paull, 
2005) (Fig.1.16). This occurs independently of ATM/ATR and leads to the 
recruitment and activation of ATM. BRCA1 was proposed to act as a mediator in this 
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process, because it binds DSB independently of ATM activation and can recruit ATM 
to the damage (Kruhlak et al., 2006).  
On the other hand, the generation of ssDNA formed at stalled replication forks leads 
to activation of the ATR checkpoint pathway. ssDNA formation leads to the binding 
of RPA and subsequent recruitment of the ATR-ATRIP, and the 9-1-1 (Rad9-Rad1-
Hus1) and Rad17 complexes. Another mediator protein that is recruited and is 
required DNA replication and checkpoint signaling is TopBP1. TopBP1 has been 
shown to bind the 9-1-1 complex and also contains a domain that can bind ATRIP and 
stimulate ATR activity (Kumagai et al., 2006). ATR is also activated by ssDNA 
generated during DSB resection by the Mre11-CtIP complex leading to the 
downstream recruitment of additional proteins as described above. 
Events downstream of damage-sensing strengthen the initial interaction and recruit 
additional proteins to the sites of the DNA damage. At the site of DNA damage, the 
variant histone H2AX gets phosphorylated at serine 139 by ATM, ATR and DNA PK 
(Rogakou et al., 1998). This phosphorylation then directly recruits Mdc1, which in 
turn acts to amplify H2AX phosphorylation over megabases of DNA possibly by 
tethering ATM or preventing H2AX dephosphorylation (Stucki and Jackson, 2006). 
Mdc1 and H2AX also allow the recruitment to sites of damage of many additional 
factors - like 53BP1, p53 etc. - driving the repair process (Fig.1.16). Mdc1 
phosphorylation also leads to ubiquitination events at the sites of DSBs, which further 
acts as a signal to assemble repair proteins. Phosphorylation of Mdc1 leads to the 
recruitment of an E3 ubiquitin ligase UBC13-RNF8 which ubiquitinates H2AX and 
possibly other proteins, in order to recruit 53BP1 (Huen et al., 2007; Kolas et al., 
2007). 
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 Fig.1.16. Model for the activation of DDR in response to DSB. Adapted from Su, 2006 
Signals initiated by the sensors very rapidly transduce to ATM and ATR kinases, 
which are both extremely large proteins that phosphorylate a great number of 
substrates. In humans, mutations in ATM cause ataxia telangiectesia, a rare autosomal 
recessive disease characterized by cerebellar degeneration, immunodeficiency, 
genome instability, clinical radiosensitivity and predisposition to cancer (Shiloh, 
1997). The protein kinase activity of ATM is minimal or low but can be stimulated in 
vivo by agents that induce DSBs in vivo and by linear DNA in vitro. Activated ATM 
phosphorylates many proteins, including BRCA1 (Cortez et al., 1999), NBS1 (Lim et 
al., 2000), Chk2 and p53 (Banin et al., 1998; Canman et al., 1998), as well as itself 
(Bakkenist and Kastan, 2003) in the sequence context of SQ or TQ. ATM under 
unstressed conditions exists as a homodimer in which tight intermolecular binding to 
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a protein domain at around Ser1981 physically blocks the kinase domain. DSBs cause 
a conformational change in the ATM protein that stimulates the kinase to 
phosphorylate Ser1981 by intermolecular autophosphorylation, resulting in 
dissociation of the homodimer. The conformational change does not appear to require 
binding to the site of DNA damage, but results from some change in the higher-order 
chromatin structure. Such chromatin changes can be sensed at some distance away 
from the DSB site. ATM kinase activity is also regulated by binding to Mre11 that 
enhances its ability to phosphorylate substrates in vitro (Lee and Paull, 2005). Thus 
ATM activity is likely to be regulated by two distinct events, one being the 
intermolecular autophosphorylation of ATM and dissociation of its homodimer 
induced by unknown chromatin changes, and the other, recruitment of the activated 
ATM to the kinase substrates. 
ATR is the initiator of the checkpoint response to a wide variety of agents that cause 
replication forks to stall. As discussed above, it is also required for the response to 
DSB, by getting recruited to ssDNA generated by DSB resection. The gene encodes a 
protein of 303 kDa with a C-terminal kinase domain and regions of homology to other 
PIKK family members. ATR deficiency in mice results in early embryonic death 
(Brown and Baltimore, 2000) and mutations causing a partial loss of its activity have 
been reported to be associated with the human autosomal recessive disorder Seckel 
syndrome (O'Driscoll et al., 2003). As with ATM, ATR is capable of specifically 
phosphorylating serine or threonine residues in SQ/TQ sequences. Unlike ATM, 
however, there is no measurable change in the kinase activity of ATR, suggesting that 
it may be constitutively ready to phosphorylate substrates but that its functions may 
be largely dependent on its subcellular localization. In human cells, ATR exists in a 
stable complex with ATRIP (Cortez et al., 2001). Given that RPA, an ssDNA-binding 
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protein, stimulates in vitro binding of ATRIP to ssDNA (Zou and Elledge, 2003), it is 
possible that the ATR–ATRIP complex is recruited at sites of DNA damage by means 
of the binding of ATRIP to RPA. ATR is thought to have a  pivotal function in the 
normal cell cycle because, differently from ATM, it is essential for embryonic 
development. The observation that RPA is involved in DNA replication (Dutta and 
Stillman, 1992) and a component of the DNA replication fork led to a model in which 
ATR–ATRIP localizes to sites of this fork, monitoring the progression of DNA 
replication. Once the active ATR is translocated to DNA replication foci, it can 
phosphorylate and activate Chk1. This model is consistent with the observation that 
Chk1 is also essential for embryonic cell viability (Liu et al., 2000; Takai et al., 
2000). Also, it has been reported that ATR regulates late origin firing of DNA 
replication (Shechter et al., 2004). Therefore, ATR appears to be a multi-functional 
kinase that regulates several distinct events from S phase to M phase. 
Among the prominent substrates of the apical checkpoint kinases ATM and ATR are 
the two serine/threonine checkpoint effector kinases CHK2 and CHK1 (Fig1.17). 
Although there is some cross-talk between ATM and CHK1, in general the ATM and 
ATR mediated phosphorylations trigger preferentially the activation of CHK2 and 
CHK1 respectively (Bartek and Lukas, 2003).  Phosphorylation of CHK2 renders it 
freely diffusible in the nucleoplasm, spreading DDR signaling by phosphorylating its 
substrates throughout the nucleoplasm (Lukas et al., 2003). Similarly, once CHK1 is 
activated by phosphorylation, mainly by ATR but also by ATM, it is not retained at 
DNA lesions and diffuses throughout the nucleus (Bekker-Jensen et al., 2006). 
Ultimately, checkpoint enforcement results from multiple, often redundant, signaling 
pathways that converge on key decision-making factors, such as p53 and the CDC25 
phosphatases (Fig.1.17). DNA damage induced CDC25 inactivation causes a rapid 
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cell-cycle arrest, as these phosphatases are essential for proliferation (Mailand et al., 
2000). In contrast, slower p53 induction following phosphorylation by DDR kinases 
(Turenne et al., 2001) leads to its stabilization and enhancement of its ability to 
induce the transcription of p21, a cyclin-dependent kinase inhibitor (Deng et al., 
1995), which triggers a stable cell-cycle arrest. 
           
Fig.1.17. Model for the signal transduction cascade during checkpoint signaling. Modified from 
Fabrizio d’Adda di Fagagna 2008 
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1.4 DNA damaging agents as chemotherapeutics 
 
Cancer chemotherapy comprises a wide range of treatments for cancer patients, 
aiming at killing cancer cells more effectively than normal tissue cells. Therapies 
therefore need to exploit specific molecular and cellular features of the cancer cells 
they are aiming to eliminate. Cancer cells proliferate more rapidly than their normal 
counterparts, so most cancer drugs target factors required for cell cycle. The most 
common means of targeting the cell cycle is to exploit the effect of DNA-damaging 
drugs. DNA damage causes cell-cycle arrest and cell death either directly or following 
DNA replication during the S phase of the cell cycle. Cellular attempts to replicate 
damaged DNA can cause increased cell killing, thus making DNA-damaging 
treatments more toxic to replicating cells than to non-replicating cells. However, the 
toxicity of DNA-damaging drugs can be reduced by the activities of several DNA 
repair pathways that remove lesions before they become toxic. Since the efficacy of 
DNA damage-based cancer therapy can be boosted by specific defects in DNA repair 
pathways, synthetic lethal approaches are becoming increasingly popular for the 
treatment of specific cancers in which one of the DNA repair pathways is 
compromised. Synthetic lethality arises when inactivation of a specific cellular 
function leads to cell death in combination with another genetic defects or treatments, 
whereas each of this events is per se compatible with life. A typical example of 
"synthetic lethality"-approach for chemotherapy - i.e. the use of PARP inhibitors for 
treatment of cancers where HR is compromised - will be discussed below.  Thus, 
more in general, DNA repair mechanisms constitute promising targets for novel 
cancer treatments. 
Many anti-cancer drugs employed in the clinic are highly efficient in killing 
proliferating cells. High levels of DNA damage cause cell-cycle arrest and cell death. 
49
_____________________________________________________________
                           INTRODUCTION
_____________________________
Also, DNA lesions that occur in S phase of the cell cycle can impede replication fork 
progression, resulting in the formation of replication-associated DSB, considered to 
be the most toxic of all DNA lesions. Common types of DNA damage that interfere 
with the DNA replication process are chemical modifications (adducts) of DNA 
bases, created by reactive drugs that covalently bind DNA either directly or after 
being metabolized in the body (Fig.1.18). These alkylating agents are grouped in two 
categories: 1) monofunctional alkylating agents with one active moiety that modifies 
single bases (alkyl sulfonates, Nitrosourea compounds and Temozolomide) and 2) 
bifunctional alkylating agents that have two reactive sites and crosslink DNA with 
proteins or, alternatively, cause DNA intra-strand crosslinks and inter-strand 
crosslinks (Nitrogen Mustard, Mitomycin C and Cisplatin). Inter-strand crosslinks 
pose a severe block to replication forks and the mechanisms for replication 
completion in the presence of these adducts are still largely elusive.  Antimetabolites, 
such as 5-fluorouracil (5FU) and thiopurines, resemble nucleotides, nucleotide 
precursors or cofactors required for nucleotide biosynthesis and act by inhibiting 
nucleotide metabolism pathways, thus depleting cells of dNTPs. They can also impair 
replication fork progression by becoming incorporated into the DNA (Swann et al., 
1996). In general, the molecular mechanisms through which anti-metabolites induce 
cell death are poorly understood. 
Another means of interfering with replication is to exploit DNA strand breaks that 
arise naturally during the process of DNA synthesis (Fig.1.16). Topoisomerases 
resolve torsional strains imposed on the double helix during DNA replication or 
during termination by creating single stranded nicks or double stranded breaks. 
Resealing of these breaks can be prevented by the use of topoisomerase poisons that 
trap the enzymes in complex with the DNA. The nature of the damage that is caused 
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depends on which type of enzyme is targeted. Top2 poisons like Etoposide cause 
DSBs during late replication or during mitosis, while Top1 poisons like Camptothecin 
have been thought to cause replication-associated DSBs during replication elongation 
(Hsiang et al., 1985; Markovits et al., 1987). The cytotoxicity associated with this 
treatment is discussed in more details below and is the subject of study in this thesis.  
Ionizing radiation and radiomimetic agents such as bleomycin cause replication 
independent DSBs that can kill non-replicating cells (Fig.1.16). In addition, such 
treatments can also rapidly prevent DNA replication by activation of cell-cycle 
checkpoints to avoid formation of toxic DNA replication lesions. 
         
Fig.1.18. Schematics showing the different types of chemotherapeutics used. Modified from 
Helleday et al., 2008 
 
 
 
 
 
51
_____________________________________________________________
                           INTRODUCTION
_____________________________
 1.4.1 Topoisomerase inhibition 
DNA undergoes conformational and topological changes during many cellular 
processes such as replication and transcription. Topoisomerases have evolved to solve 
these conformational and topological changes in DNA. They perform their functions 
by introducing transient protein-bridged DNA breaks on one (type I) or both DNA 
strands (type II). Both types of topoisomerases have been isolated from mammalian 
cells. While Top1 can relax supercoiled DNA, only Top2 can unlink two intertwined 
DNA circles via its strand-passing activity (Liu, 1989). Inhibition of topoisomerase 
activity has been frequently used in cancer chemotherapy. 
Top1 enzymes are particularly vulnerable to inhibitors like Camptothecin (CPT) 
during their transient cleavage step (cleavage complex). Top1 cleavage complexes 
(Top1ccs) are normally transient, but CPT and its derivatives specifically and 
reversibly trap these complexes. The religation of TOP1ccs requires nucleophilic 
attack of the tyrosyl-DNA-phosphodiester bond by the free DNA end (the 5′-hydroxyl 
end). It requires perfect alignment of the 5′-hydroxyl-DNA end with the tyrosyl-
phosphodiester bond to be religated back, a step inhibited by the formation of stable 
Top1ccs by CPT. 
Replication-fork collision with the Top1ccs  has been proposed to be the primary 
cytotoxic mechanism for Top1 inhibitors in dividing cells (Holm et al., 1989). This 
hypothesis is known as the " Replication run-off "theory as the leading strand is  
thought to be replicated up to the last nucleotide at the 5′ end of the Top1cc 
(Fig.1.19). This hypothesis has been supported by data implicating the role of DNA 
damage markers like H2AX phosphorylation and homologous recombination factors 
in CPT induced cytotoxicity (Pommier, 2006). 
52
_____________________________________________________________
                           INTRODUCTION
_____________________________
 Fig.1.19. Model depicting the Replication run-off theory. Modified from Pommier, 2006. 
A recent report has however challenged this hypothesis, by showing that Top1 
inhibitors also prevent the relaxation activity of Top1, thus leading to the  
accumulation of positive supercoiling  on the DNA, which may contribute to Top1 
poison-mediated cytotoxicity (Fig.1.20). The cytotoxic potential of increased 
topological stress induced by Top1 inhibitors during DNA replication is the main 
subject of this PhD thesis. 
 
Fig.1.20. Model showing the accumulation of positive supercoils in response to Top1 inhibition 
and its potential contribution to cytotoxicity. Modified from Koster et al., 2007 
 
Top1ccs can however be removed from the DNA by the tyrosyl-DNA-
phosphodiesterase (TDP1) excision pathway, which involves the XRCC1 and base 
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excision repair (BER) complex. TDP1 was identified as an enzyme that hydrolyses a 
tyrosyl residue from the 3′ end of DNA in yeast (Pouliot et al., 1999). In humans, 
mutations inactivating TDP1 are responsible for the autosomal recessive disease 
spino-cerebellar ataxia with axonal neuropathy (SCAN1)(Takashima et al., 2002). 
TDP1 forms macromolecular complexes with the BER complex including XRCC1, 
which has been proposed to repair the lesion formed by the Top1ccs.  In addition, 
Top1 needs to be proteolytically degraded or denatured for efficient Tdp1 activity 
(Interthal et al., 2005). This appears to be mediated by ubiquitination events, as Top1 
ubiquitination and degradation have also been observed following camptothecin 
treatment (Desai et al., 1997).  
Top2 plays a major role in removing the intertwining of the two newly replicated 
strands (precatanes) generated behind the replication fork (Zechiedrich and 
Cozzarelli, 1995). It has also been shown to assist the completion of  DNA replication 
by its enrichment at termination zones (Fachinetti et al., 2010). In contrast to Top1 
inhibitors, Top2 inhibitors, such as etoposide and ICRF 193, act late during 
replication or during mitosis. The cytotoxicity induced by etoposide treatment has 
been attributed to the formation of stable cleavage complex of the drug with Top2, 
inhibiting the religation step and thus resulting in DSB (Bromberg et al., 2003). ICRF 
193 treated cells on the other hand have problems to progress beyond mitosis, with 
defects in chromosome segregation leading to hyper-catenated DNA which elicits a 
checkpoint response (Baxter and Diffley, 2008). 
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1.4.2  PARP inhibition. 
PARP is a nuclear protein responsible for the detection and signaling of single strand 
DNA breaks (SSB) to the enzymatic machinery involved in the SSB repair. PARP 
activation is an immediate cellular response to metabolic, chemical, or radiation-
induced DNA SSBs or DSBs. Once PARP detects a DNA damage it binds to the 
DNA, and, after a structural change, begins the synthesis of a poly(ADP-ribose)chains 
(PAR) as a signal for other DNA repair enzymes (Fig.1.19).  Some of the factors 
recruited to the damage include proteins of the BER pathway such as DNA ligase III, 
DNA polβ and scaffolding proteins such as XRCC1. After repair, the PAR chains are 
degraded via PAR glycohydrolase (PARG). NAD+ is required as substrate for 
generating ADP-ribose monomers (Rouleau et al., 2010). In addition to its role in 
BER described above, PARP is involved in several other nuclear processes. It has 
recently been observed that rapid recruitment of Mre11 and ATM, crucial 
components of the homologous recombination machinery, to DNA DSBs is 
dependent on PAR synthesis (Haince et al., 2007; Haince et al., 2008), which suggests 
that PARP acts as a facilitator of homologous recombination. Studies in mammalian 
cells indicate that recruitment of Mre11 to assist replication fork restart is also 
dependent on PARP (Bryant et al., 2009). In vitro studies have also implicated the 
role of PARP in NHEJ (Audebert et al., 2004). Although PARP is spontaneously 
recruited to sites of DSBs, it does not seem to play a direct role in DSB repair (Yang 
et al., 2004). PARP1 can also regulate transcription by modulating chromatin 
structure, altering DNA methylation patterns, acting as a co-regulator of transcription 
factors and interacting with chromatin insulators (Caiafa and Zlatanova, 2009). 
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 Fig1.20. Model suggesting the role of PARP in DNA repair. Modified from Rouleau et al 2010. 
 
Recently, small molecule inhibitors of PARP have been developed as chemotherapy 
sensitizers for the treatment of cancer. It has been demonstrated that BRCA1-deficient 
and BRCA2-deficient cells, when compared with matched wild-type cells, are 
profoundly sensitive to PARP inhibitors (Bryant et al., 2005). In some cases, BRCA2-
deficient cells were more than 1000 times more sensitive to nanomolar concentrations 
of PARP inhibitor (Farmer et al., 2005), suggesting the possibility of a highly 
selective therapy. It is likely that PARP inhibitors target the HR deficiency in BRCA-
deficient cells. PARP is documented to be crucial for the repair of single-strand DNA 
breaks (SSBs) and PARP inhibitors cause an increase in persistent SSBs (Boulton et 
al., 1999). It was shown that PARP inhibition also increases nuclear Rad51 foci 
(Schultz et al., 2003), a marker of ongoing HR repair. Taken together, these different 
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lines of evidence suggest that PARP inhibition could lead to accumulated SSBs and 
resultant collapsed replication forks/DSBs. In face of this thread, HR-defective cells 
(frequent in certain types of cancer) would be unable to maintain genome integrity 
and show markedly increased sensitivity to PARP inhibition. Consistent with the HR 
defect in BRCA-deficient cells being the primary cause of PARP inhibitor sensitivity, 
cells with deficiencies in a number of other HR proteins are also sensitive to PARP 
inhibitors (McCabe et al., 2006). 
 
Table1.2. Table showing different PARP inhibitors, their combination with DNA damaging 
drugs and the ongoing clinical trials eploiting these treatments.  Modified from Rouleau et al., 
2010 
 
An alternate approach for PARP mediated chemotherapy has been the use of a 
combination of DNA damaging agents along with PARP inhibitors. The DNA 
damaging agents that showed marked chemosensitization in combination with PARP 
inhibitor include Methylating agents, Topoisomerase1 inhibitors, DNA crosslinkers 
and ionizing radiation (Rouleau et al., 2010)(Table1.2). Phase I and Phase II trials of 
several PARP inhibitors in combination with DNA damaging agents are ongoing and 
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might offer new important perspectives to cancer chemotherapeutic approaches 
(Rouleau et al., 2010). 
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2. RESULTS 
2.1 Top1 inhibition results in slow fork progression in yeast. 
To address the effects of CPT induced Top1 poisoning in vivo in yeast, we monitored 
replication kinetics along the chromosomes by ChIP-chip and Bromodoeoxyuridine 
(BrdU) incorporation in synchronized S. cerevisiae cells (Katou et al., 2003). We 
compared length and distribution of BrdU tracks in yeast cells, released from a G1 
block in presence or absence of CPT. The cells were pre-synchronized in S-phase by 
the addition of α-factor and released at 16°C by media replacement in the presence of    
        
Fig.2.1. Representative BrdU replication profiles (ChrIII, 1-200kb) in presence or absence of 
50µM CPT. Genome wide BrdU incorporation maps were obtained at different time points (45, 60 and 
75 min) after release from G1 block at 16°C in the presence (right) or absence (left, NT) of 50µM CPT.  
Representative data are shown here for Chromosome III (1-100kb; 100-200kb). For genome-wide 
analysis of fork progression, we focused on a mid-S phase time point (60 min), where the highest 
number of replicons could be simultaneously analyzed. The position of left and right tails of each BrdU 
peak was compared in presence and absence of CPT and only distances above 1kb were considered 
significant, as exemplified by the red, full (+CPT) and empty (NT) arrowheads. An example of fork 
delay considered "non-significant" is marked by black (full, +CPT; empty, NT) arrowheads.  
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Pronase. To follow the origin firing and progression of replication forks, a kinetic 
analysis was performed at 45, 60 and 75 min time points after G1 release. Small BrdU 
peaks were visible and comparable in width at all early replication origins (*) at the 
earliest time point (45 min) in presence and absence of CPT, showing that CPT 
treatment does not affect timing and distribution of origin firing (Fig.2.1). We then 
focused our analysis on a mid-S phase time point, where the highest number of 
replicons could be simultaneously analyzed. BrdU track extension was measured as 
reliable read out of fork progression in presence or absence of CPT. While we never 
found a CPT treated fork moving  
      Fig.2.2. CPT-treated S. 
cerevisiae cells have slower 
fork progression (A) Examples 
of fork movement across a 
region of chromosome IV, 
monitored by BrdU 
incorporation. CPT-induced 
fork delay (red arrow heads) 
was scored measuring the 
distance between BrdU track 
tails in presence and absence of 
50µM CPT (see also Table 2.1 
at the end of the results section). 
(B) Graphical representation of 
the percentage of delayed (kb) 
forks upon CPT treatment. (C) 
Examples of termination zones 
showing impaired fork 
progression upon CPT 
treatment. Horizontal red bars 
indicate recently characterized 
TERs (Fachinetti et al., 2010). 
 
 
 
faster than the untreated counterpart, we did find ≈35% of all active forks (119/350) 
showing a delay of at least 1kb in presence of CPT (Fig.2.2A and 2.2B). A small 
fraction of forks (≈10%) was delayed by more than 2kb (Fig.2.2B). Two 
chromosomal features previously linked to fork pausing - centromeres and 
termination zones (Fachinetti et al., 2010; Greenfeder and Newlon, 1992) - were also 
analyzed for CPT-induced delay in fork progression. 5 of the 8 (62%) centromeres 
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undergoing replication at the timepoint chosen for analysis were delayed in 
replication upon CPT treatment (Fig.2.2A and Table 2.1, at the end of this Results 
session). Similarly, we could also detect delayed replication termination at 12 of 16 
(75%) recently characterized termination regions (TERs) (Fachinetti et al., 
2010)showing converging forks in our experiment (Fig.2.2C).  
An independent experiment revealed a similar proportion of delayed forks (107/350; 
30.5%). Despite the unavoidable, subtle variability in the kinetic of S phase entry in 
the two experiments, 53 forks (49.5%) were found to be delayed at identical 
chromosomal positions.      
 
Fig.2.3. 2D-gel analysis of replication intermediates from wild type S. cerevisiae cells in presence 
or absence of CPT. (A) Chromosome III region adjacent to ARS305 with indication of the probes 
used for 2D-gel analysis  . (B) Schematic representation of replication intermediates visualized by 2D-
gels. (C) Time-course resolution of replication intermediates obtained from wild type cells released 
synchronously from G1 arrest at 25°C in presence or absence of 50µM CPT. 
 
To further confirm the delay in fork progression in response to CPT, a bi-dimensional 
gel electrophoresis (2D-gels) was performed on wild yeast cells mock- or CPT-treated 
for the resolution of replication intermediates at different time points (Fig.2.3). 
Results showed a delayed detection of "large bubbles" at ARS305 (35 min). Since we 
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found  (Fig.2.1) that CPT treatment does not affect the timing of origin firing 
(including ARS305), the delay seen in the detection of large bubbles is indicative of 
delayed progression of the forks emanating from the origin. Furthermore, replication 
fork progression monitored through the indicated adjacent fragments (A, B, C and D) 
appears significantly impaired by CPT treatment (35, 50 min): the forks emanating 
from ARS305 invade fragments A, B and C with approximately 15 min delay in the 
presence of CPT, although later resolution of replication intermediates (65 min) is 
comparable with and without CPT suggesting that the delay observed upon CPT 
treatment is transient. Together, results in Fig2.1-2.3 show significant proportions of 
yeast forks slowed down in response to CPT treatment. 
 
2.2 Replication fork delay upon Top1 inhibition is not associated with detectable 
DSB in yeast. 
 
Fig.2.4. Detection of chromosomal breakage in synchronized, CPT-treated wt and DSB-repair 
defective (rad52) S. cerevisiae cells. Wt and rad52Δ cells were arrested in G1 with α -Factor and 
released in the presence or absence of 50µM CPT. Culture samples were processed for Pulse Field Gel 
Electrophoresis detection of DSB. The EtBr-stained gel is shown in reverse contrast. α-Factor arrested 
cells untreated (NT) or irradiated with 500 Gy (IR) were used as negative and positive control of 
chromosomal breakage, respectively. 
 
Since fork stalling upon CPT treatment has been consistently linked to the formation 
of DSB, we expected the observed widespread fork delay in our experiments to be 
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associated with detectable DSB by fork collapse. Pulse Field Gel Electrophoresis 
(PFGE) was performed after treatment with CPT in wild type yeast cells, as well as  
rad52Δ  cells which are defective for HR-dependent DSB repair (Fig.2.4). 
Irradiation-induced DSB used as positive control led to markedly reduced signals for 
the chromosomal bands and appearance of a smear over the PFGE lane, particularly 
evident towards the smaller chromosomal bands (IR), suggesting chromosomal 
breakage. Upon release into S-phase of both wt and rad52 cells, the chromosomal 
bands were, as expected, transiently retained within the plugs during replication (30 
min) due to their highly branched structure. The bands promptly reappeared at later 
time points (≥60 min) despite the CPT treatment, correlating with completion of bulk  
DNA replication in all cases. Furthermore, we found no evidence for CPT-induced 
chromosomal breakage (band smearing) in either wt or rad52 cells at any time point 
during the kinetic. The slight reduction in the intensity of the chromosomal bands in 
CPT treated compared to untreated rad52 cells, in the absence of any detectable 
smear, may suggest partial chromosomal retention in the PFGE plugs, consistent with 
the possible requirement of HR for late steps of DNA replication/segregation upon 
CPT treatments. 
Although ChIP-chip data showed a genome wide fork slowdown (Fig.2.2), it is still 
formally possible that Top1cc are too sparse under these experimental conditions and 
that the PFGE assay may not be sensitive enough to detect CPT-induced DSBs in 
yeast cells. We thus investigated the presence of DNA breaks by activation of the 
DNA damage checkpoint, as even a single, unrepaired DSB was shown to 
phosphorylate and activate the central yeast checkpoint kinase Rad53 (Pellicioli et al., 
1999). CPT treatment did not lead to DNA damage checkpoint activation (Rad53 
phosphorylation) in wild type cells (Fig.2.5A). On the contrary, DSB-repair defective 
rad52 cells did show activation of the DNA damage checkpoint, but only after at least 
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90min from G1 release, a time point when bulk DNA replication is complete (Fig. 
2.5A-B) and replication intermediates appear to be resolved (Fig.2.3C and Fig.2.4). 
Furthermore, rad52 cells failed to progress into the next cell cycle after treatment 
(Fig.2.5B-C), but both wild type and rad52 cells showed unaffected S phase 
progression upon CPT treatment and completed bulk DNA replication within 60 min 
after G1 release (Fig.2.5B). Altogether these results suggest that DSB, if any, can be 
temporally uncoupled from CPT-induced fork slowdown in yeast and that HR-repair 
is required only at the end of S-phase. 
 
 
Fig.2.5. Checkpoint analysis, cell cycle progression and growth curve in synchronized, CPT-
treated wt and DSB-repair defective (rad52) S. cerevisiae cells. (A) Western blot analysis for the 
activation of checkpoint protein Rad53 in CPT-treated yeast cells. Wild type and rad52Δ cells were 
arrested in G1 with α -Factor and released in the presence or absence of 50µM CPT. Total protein 
extracts at the indicated time points were probed for total-Rad53 and phospho-specific Rad53. (B) 
Analysis of cell cycle progression in response to CPT in wild type and rad52Δ cells. Wild type and 
rad52Δ cells were synchronized and treated as in (A). Cell cycle progression was monitored at the 
indicated time points by FACS analysis of DNA content (Propidium Iodide). (C) Growth curve 
analysis in response to CPT in wild type and rad52Δ cells. Wild type and rad52Δ cells were 
synchronized and treated   as in  (A).  Cell   number was counted at the indicated time points and  
used to build the growth curves.  
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2.3 CPT induces slow fork progression at low concentrations in mammalian 
cells. 
 
Fig.2.6. CPT induces slow fork progression in human cells. (A) In vivo analysis of replication fork 
progression by cell labelling with halogenated nulceotides (CldU and IdU), DNA fiber spreading and 
immunodetection of replicated tracts in Mock- or CPT-treated U2OS cells. CldU/IdU-containing tracts 
were immunostained in red and green respectively. Two representative fibers per experiment are 
shown. (B) The smoothened histogram distribution shows green (IdU) tract length in presence or 
absence of CPT. (C) The graph represents length in µm of DNA tracts synthesized before [CldU, red, 
left] and after mock (NT) or CPT treatment (25nM, 1µM) [IdU, green, right]. At least 100 tracts were 
scored for each dataset.  Whiskers indicate 10-90 percentile. T test according to Mann-Whitney, results 
are ns not significant, * p ≤  0.05, *** p ≤  0.0001. (D) Identical experiment as in A), but DNA fibers 
have been counterstained with a "total DNA" (antiguanine) antibody (see the representative fiber below 
the graph). Fork progression in mock- or CPT 25nM-treated cells was scored by standard tract analysis 
as in A (two datasets on the right) or by restricting the analysis to intact forks ("total DNA stain"; red + 
green tracts flanked by continuous DNA stain, as in the inset).  
 
As the poor permeability of standard S. cerevisae strains to CPT limits the number of 
Top1ccs induced at soluble CPT concentrations, we shifted our analysis in cultured 
human cells, where CPT-induced effects are already detectable in the nanomolar 
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range. S phase-checkpoint proficient U2OS cells were used for most experiments. 
To analyze the effects of CPT on fork progression at single-molecule level, we took 
advantage of DNA chromosome spreads and immunofluorescent detection of 
replicated tracts, upon incorporation of halogenated nucleotides (CldU and IdU). 
CldU and IdU were added sequentially to the U2OS cells for 30 min each and CPT (0, 
25nM or 1µM) was added during the IdU pulse. CldU- and IdU-incorporated tracts 
were identified on the fibers by specific antibodies and visualized in red and green 
respectively. 
 
Fig.2.7. Cells treated with CPT show sister-fork asymmetry. DNA fibers from mock- and CPT-
treated cells were scored for fork symmetry, comparing lengths (shorter over longer ratio) of green 
tracts departing from the same origin. (A) One representative picture of mock- and CPT 25nM-treated 
forks that were scored for sister fork symmetry. (B) Histogram analysis of sister tract ratio in the 
experiment in (A). At least 100 tracts were scored for each dataset. 
 
We observed that treatment with 25nM CPT induced a global, marked delay in 
replication fork progression, while only marginal further decrease was induced by a 
40-fold higher CPT dose (1µM) (Fig2.6A-C). The small, but significant difference in 
the length of red tracts between mock and 25nM CPT treated cells (Fig.2.6C) reflects 
CPT-induced fork slow-down, occurring immediately after addition of the drug, while 
residual CldU is still incorporated into the nascent DNA. The DNA fibers were also 
counterstained with a "total DNA" (antiguanine) antibody to focus our analysis on 
intact forks and address the possibility that the shorter tracts observed after CPT 
treatments were due to replication fork breakage (Fig.2.6D). The results revealed that 
the data sets obtained by both approaches were comparable indicating that the 
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replication fork slow down induced by 25nM CPT treatment is not accompanied by 
extensive fork breakage. 
Furthermore, even the lowest concentration of CPT (25nM) used in the treatment of 
cells resulted in a significant degree of sister fork asymmetry (Fig2.7). Overall these 
data suggest that replication forks are frequently slowed down or stalled in response 
to even low (nM) CPT concentrations. 
 
2.4 Slow fork progression at low CPT concentrations does not induce detectable 
DSB in mammalian cells. 
 
Fig.2.8. DSB Detection by PFGE in irradiated, HU-treated and CPT-treated U2OS cells. (A) 
PFGE analysis for DSB detection upon treatment of U2OS cells with different doses (3-40 Gy) of 
ionizing radiation. (B) DSB signals were quantified by ImageJ and normalized to unsaturated signals of 
DNA retained in the wells. The graph integrates results from three independent experiments and shows 
DSB levels relative to untreated conditions (NT, dashed line). (C) PFGE analysis for DSB detection 
upon 30 Gy ionizing radiation (IR, positive control), 24h treatment with HU 5mM (HU, positive 
control) and 4h treatment of U2OS cells with 0, 25nM or 1µM CPT. 
 
To further investigate if the global fork slowdown observed upon CPT treatment is 
associated with formation of DSB by fork collapse, we performed PFGE analysis for 
the detection of DSBs. By this optimized PFGE procedure, broken DNA fragments 
ranging from 300kb to 5MB can be compacted into one single band, which helps 
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quantification of broken chromosomal DNA (Hanada et al., 2007). 
Testing the sensitivity of the PFGE assay was one of the requirements of the 
experiment, as earlier PFGE protocols were considered not sensitive enough to detect 
a low number of DSBs. Thus, to test the sensitivity of our assay, DNA from cells 
treated with different doses of IR (3-40 Gy) was analyzed by this PFGE approach. 
DSB were reproducibly detected above background levels already at the minimal 
irradiation dose (3 Gy) (Fig2.8A-B). Similar results were obtained using two different 
irradiation apparatuses. As one Gray has been reported to induce approximately 30 
DSB/cell (Ward 1988), we could conclude that this assay - due to the compaction in a 
single band of broken fragments of various size - is sensitive enough to reproducibly 
detect less than 100 DSB/cell. 
We thus treated U2OS cells with 25nM and 1µM CPT to assess chromosome 
breakage upon CPT doses. Although DSBs could be clearly detected by our PFGE 
assay in 1uM CPT, we could not detect breaks above the background level when 
treating U2OS cells with 25nM CPT. These results suggest that CPT induced fork 
slowing can be largely uncoupled from DSB formation (see Discussion). 
 
2.5 Slow fork progression in response to CPT in human cells and Xenopus egg 
extracts is HR-independent.  
One of the main implications of the "run-off theory" is that forks collapsed upon CPT 
treatments would require HR to restart. Furthermore, as CPT treatments slow down 
replication forks genome-wide (Fig.2.6), HR-repair should be required for S-phase 
completion. To test this hypothesis, we investigated the effects of CPT on bulk DNA 
replication of synchronized Mock transfected (siCtrl) and HR defective (siCtIP) cells.  
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 Fig.2.9. Synchronization of U2OS cells in S-phase. (A) Flow cytometric analysis (Propidium Iodide) 
of the synchronization procedure in mock-transfected (siCtrl) and HR defective (siCtIP) U2OS cells. 
(B) Western Blot analysis for the knockdown of CtIP and checkpoint status of SiCtrl and siCtIP cells 
during the synchronization procedure. Whole cell protein extracts from the indicated time points during 
the synchronization procedure were probed for CtIP, pChk1 and pATM. TFIIH was used as a loading 
control. 30Gy IR was used as positive control for Chk1 and ATM activation 
 
Cells were synchronized by treating with 2mM thymidine (Thy) for 24h. The cells 
were then washed and released for 3h (Rel) before treating them with 75ng/ml 
nocodazole for 12h (Noc). The cells were finally released into the following cell cycle 
by washing and incubation in fresh medium. 10h after release (Rel) U2OS cells enter 
synchronously the next S phase (Fig.2.9A).  
Analysis into the checkpoint status of the cells during the synchronization procedure 
showed that, despite some Chk1 activation during the thymidine treatment and 
following release procedure (Fig.2.9B), even the HR-defective cells showed no sign 
of checkpoint activation (pChk1, pATM) when entering the next S-phase after release 
(10h) (Fig.2.9B), suggesting that they are undergoing bona fide unperturbed DNA 
replication. Untreated cells traverse S phase in 6-8h (10-18h) (Fig.2.10A) and 
complete a full cell cycle in about 24h, which is consistent with the standard doubling 
time (24h) and with the detection of 25-35% S phase cells in asynchronously growing 
U2OS cells. On the other hand, treatment of mock transfected (siCtrl) cells with 
25nM of CPT at the entry of S-phase (10h) resulted in a massive slowdown of cells in 
S-phase and delayed completion of bulk DNA replication by several hours. 
Furthermore, treating the cells with 1µM CPT at the entry of S-phase lead to a 
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persistent replication block which could not be overcome to finish bulk DNA 
replication (Fig.2.10A). Notably, effective downregulation of CtIP (Fig.2.10B) during 
the synchronization procedure, known to impair human HR and sensitize cells to CPT 
treatments (Sartori et al., 2007), did not induce any further delay in S-phase 
completion than that observed in CPT-treated, mock-transfected cells. 
 
 
 
Fig.2.10. Upon mild CPT treatments, human cells can slowly, but successfully maintain fork 
progression and complete S phase, even in the absence of HR-mediated DSB repair. (A) Analysis 
of cell cycle progression by flow cytometric detection of DNA content upon synchronization of mock 
transfected (siCtrl) and HR-deficient (siCtIP) U2OS cells and CPT treatment. (B) Western blot analysis 
of CtIP depletion during the treatment of cells with CPT. (C) In vivo analysis of replication fork 
progression in Mock transfected (siLuc) and HR defective (siCtIP) cells by labelling with halogenated 
nulceotides (CldU and IdU), DNA fiber spreading and immunodetection of replicated tracts, as 
described in Fig.2.6. (D) Western blot for CtIP downregulation in the experiment in C. TFIIH, loading 
control. 
 
To further confirm this observation, we performed a DNA fiber experiment to assess 
the role of HR in the progression of single forks (Fig.2.10C). Results confirmed that 
upon effective downregulation of CtIP (Fig.2.10D), single forks showed no further 
delay in their progression rate, than that observed upon CPT treatment in mock-
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transfected cells. 
Altogether, these data suggest that HR-mediated DSB repair is dispensable for slow 
fork progression and S-phase completion in CPT-treated human cells. 
To also investigate the role of HR on bulk DNA replication in Xenopus egg extracts 
treated with Topotecan (TPT, a water soluble derivative of CPT more suitable for 
molecular investigations in this system), we depleted Rad51 from the extracts by the 
addition of GST-BRC4 peptide (Hashimoto et al., 2010). Sperm nuclei were 
incubated with egg extracts in the presence or absence of GST (mock) or GST-BRC4 
and incubated with 50 or 100µM of TPT for different times (Fig.2.11). 
 
 
Fig2.11. Homologous recombination-independent slow DNA synthesis in TPT-treated Xenopus 
egg extracts. Sperm nuclei were incubated in 10 μ l egg extract with α 32P-dATP for the indicated 
times in the presence or absence of GST (mock) or GST-BRC4 HR deficient and topotecan (50 or 
100μM). Replication products were resolved on 1% alkaline agarose gel and subjected to 
autoradiography. 
 
TPT induced a marked slow down of incorporation rates in a concentration dependent 
manner (50min, Fig.2.11), but no further reduction in the rate of DNA synthesis was 
observed upon Rad51 depletion from the extracts. These data suggest that HR is also 
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dispensable for bulk DNA replication in Xenopus egg extracts upon treatment with 
Top1 poisons. 
 
2.6. Slow DNA replication progression is not accompanied by detectable 
chromosomal breakage even upon prolonged treatment of S phase-synchronized 
human cells with low (nM) CPT doses. 
 
Fig.2.12. DSB Detection by PFGE in CPT-treated synchronized U2OS cells. U2OS cells were 
synchronized as in Fig. 9, transfected (siCtrl, A; siCtIP, B) and treated with CPT as described in Fig. 
10A. Cell samples at the indicated time points were processed for PFGE to possibly detect DSB upon 
treatment with 25nM and 1µM CPT. NC (negative control): asynchronous U2OS cells; IR (positive 
control for DSB): U2OS cells 2 hours after 40Gy irradiation. C) DSB signals were quantified by 
ImageJ and normalized to unsaturated signals of DNA retained in the wells. The graph integrates 
results from two independent experiments and shows DSB levels relative to the same time point in 
untreated conditions (NT, dashed line). 
 
To further investigate the mechanism of CPT action, we tested whether prolonged 
treatments with nM CPT doses would lead to detectable amounts of DSB in control or 
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HR-deficient cells. To do this, we used the same synchronization protocol as in 
Fig.2.10 - which allows to have S-phase synchronized cells CPT-treated for up to 14h 
(from 10h to 24h) - and assessed DSB induction by PFGE analysis (Fig.2.12). 
The results confirmed our observation in Fig. 8 with asynchronous cells: even upon 
prolonged treatment of synchronous cells, DSB were clearly detected upon 1μM CPT 
treatments, but no DSB could be detected over background level in either mock-
transfected (siCtrl) or DSB-repair defective (siCtIP) cells upon treatment with CPT 
25nM (Fig.2.12A-C). Surprisingly, we reproducibly observed that treatment with high 
concentration of CPT (1μM) led to lower amounts of DNA breakage in HR-defective 
(siCtIP) cells  than in mock treated cells (Fig.2.12B and C) (see Discussion). 
Together, these data suggest that the slow DNA replication rate observed in 
mammalian cells upon treatment with low (nM) CPT concentrations is largely 
uncoupled from DSB accumulation.	  	  
 
2.7. nM CPT treatment results in checkpoint activation independently of 
detectable DSB and break processing. 
As different kinds of damage have been shown to activate either or both the 
ATR/Chk1 and ATM/Chk1 pathway, we set out to investigate the kind of damage 
response elicited by the treatment with different CPT doses on mock-transfected 
(siCtrl) and HR-defective (siCtIP) cells synchronized in S-phase.	  	  
Our results showed that, although basal levels of checkpoint are detectable during 
unperturbed DNA replication (Fig.2.1A), both ATM/ Chk2 and ATR/Chk1 pathways 
get promptly activated by CPT treatments in synchronized cells (Fig.2.13A). 
Persistent activation of both the ATM/Chk2 and ATR/Chk1 pathways upon treatment 
with high doses of CPT (1μM) (Fig.2.13 A) should presumably be attributed to DSBs 
formation, as previously suggested (Fig.2.12). However, it was surprising to us that 
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ATM/Chk2 pathway gets clearly activated even upon mild CPT treatments (25nM), 
which do not lead to detectable DSB even upon prolonged exposure (Fig.2.13A and 
Fig.2.12), but already markedly affect replication fork rate (Fig.2.10). Furthermore, at 
these low CPT doses,Chk1 activation appears entirely independent of CtIP mediated 
DSB resection, differently from what reported at higher doses (Sartori et al., 2007). 
 
Fig.2.13. Checkpoint activation in CPT treated cells.(A) Western blot analysis of checkpoint 
activation (pATM and pChk1) on the same samples as in Fig.2.10. IR treatment with 30Gy was used as 
a positive control (IR) hasTFIIH, loading control. (B) Single-molecule analysis of replication fork 
progression in U2OS cells upon Top1 and/or Chk1 inhibition. Relative length of DNA tracts 
synthesized after mock (NT) or CPT treatment (25nM) [IdU, green]. At least 100 tracts were scored for 
each dataset. 300nM UCN01 (Chk1 inhibitor) was optionally added during the labellings. Whiskers 
indicate 10-90 percentile. T test according to Mann- Whitney, *** p ≤ 0.0001. 
 
As Chk1 is promptly activated in response to low CPT doses, we attempted to 
investigate a possible role of Chk1 activation on fork slowdown. For this purpose 
Chk1 was inhibited by UCN01 and fork progression rates were measured in the 
presence or absence of CPT. However our data, in agreement with earlier published 
data (Petermann et al., 2010) revealed that Chk1 inactivation, led "per se" to severe 
fork progression defects during unperturbed replication, thus precluding direct 
assessment of its role in CPT induced fork slowdown (Fig.2.13B). 
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2.8. Top1 poisoning results in replication fork reversal. 
To gain insight on the possible DNA structures resulting from Top1 inhibition, we 
next visually inspected the fine architecture of in vivo replication intermediates (RIs), 
exploiting a combination of in vivo psoralen crosslinking and electron microscopy 
(EM) (Lopes, 2009), already extensively used in the past to characterize the molecular 
determinants of yeast and mammalian DNA replication stress. 
 
Fig.2.14.Top1 inhibition induces fork reversal (A) Representative electron micrograph and 
schematic drawing of a reversed fork observed on genomic DNA from CPT-treated U2OS cells. The 
white arrow points to the four-way junction at the replication fork. (B) Schematic representation of the 
process of fork reversal. (C) Schematic representation showing the distinction between Holliday 
Junctions and Fork reversal. (D)Frequency of fork reversal in S. cerevisiae cells (50µM CPT, 30min), 
Xenopus egg extracts (50µM TPT, 50 min) and U2OS cells (25nM or 1µM CPT, 1h). In brackets, the 
number of analyzed molecules. 
 
This analysis revealed a significant fraction of replication forks with a fourth, 
regressed arm (reversed forks, RF) upon Top1 poisoning (Fig.2.14A). In order for a 
fork to be reversed, newly replicated strands need to be unwound from their parental 
counterparts and (when both are available) anneal with each other, forming a fourth 
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(regressed) arm at the replication fork. During this process, parental strands, 
previously unwound by the replicative helicase, are re-annealed (Fig.2.14B). 
Reversed forks can be identified by electron microscopy based on several parameters: 
1) they are detected under DNA concentrations that minimize occasional crossing of 
DNA molecules; 2) in some cases a clear rhomboid Holliday Junctions (HJ)-like 
structure is detected where the two molecules overlap, assisting the interpretation. 
Furthermore, reversed forks can be distinguished from standard HJ based on length 
measurements: reversed forks should have only two of the four arms equal in length 
(due to the same distance of the replication fork from the restriction sites on the 
replicated duplexes), while standard HJ are symmetrically positioned in respect to all 
arms (Fig.2.14C). 
A reproducible fraction of RF was observed on genomic DNA from CPT-treated 
yeast cells (25-30%) and on sperm DNA replicated in Xenopus egg extracts in 
presence of TPT (15-20%, Fig.2.14D). Remarkably, an even higher RF proportion 
(30-40%) was observed in U2OS cells replicating in 25nM CPT, while 40-times 
higher CPT doses (1µM) did not significantly increase RF frequency (Fig.2.14D). 
These data suggest that replication fork reversal is directly linked to fork slowing, 
while it is not necessarily associated with DSB formation (Fig.2.8C). 
Although termination intermediates are rare in our EM samples - 33 among the total 
689 CPT-treated RIs analyzed in this thesis - 17 of them (52%) showed one of the two 
forks reversed. Frequency of fork reversal at converging forks is thus higher than that 
observed in all systems at individual forks (Fig.2.14D), consistent with our yeast 
genomic data on fork progression (Fig.2.1C). 
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Fig.2.15. The regressed arm: analysis by electron microscopy. A) Representative electron 
micrograph of a reversed fork displaying a single sranded (ss-) regressed arm (white arrow). B) 
Statistical analysis of all identified regressed arms in the different experimental systems, in respect to 
their organization in double stranded (ds), single stranded (ss) or partially single stranded (ds/ss) DNA.  
 
A further analysis on the nature of reversed arm formed upon CPT treatment revealed 
that approximately 20-50% of the regressed arm in all experimental systems used 
exposed ssDNA stretches (Fig2.15). These results may suggest that, reversal of forks 
with proper coupling of leading and lagging strand synthesis (normal forks) would 
result in ds ("blunt")-regressed arms, and that further processing (resection) of the ds-
end may lead to the formation of ds-ss DNA stretches. Alternatively, fork reversal at a 
replication intermediate that is experiencing uncoupling of leading and lagging strand 
synthesis (uncoupled fork) may directly lead to ss-regressed arms (see Discussion). 
 
2.9 In vitro resolution of topological stress upon Top1 inhibition results in better 
fork restart in Xenopus egg extracts. 
Fork reversal has been shown to arise as a consequence of increased positive torsional 
strain on the DNA (Postow et al., 2001). Furthermore, Top1 poisons have been shown 
to induce torsional stress on the DNA by inhibition of the relaxation process (Koster 
et al 2007).  
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Fig.2.16. Effect of in vitro-resolution of topological stress on continued replication fork 
progression, upon TPT treatment of Xenopus egg extracts. In the 1st extract, sperm nuclei were 
incubated for 50 min in the presence of TPT (100µM). The nuclear fraction was isolated and divided 
equally into two aliquots, which were then incubated in the buffer with or without calf thymus Top1 
(+Top1/ –Top1). The nuclear fractions were re-isolated and incubated for the indicated times in the 2nd 
extracts (containing alpha-32P-dATP, His-Geminin, His-p27 and TPT), thus in conditions where only 
already active forks can contribute to DNA synthesis. Replication products were resolved on 0.8% 
TAE agarose gel and subjected to autoradiography. The obtained signal intensities were quantified by 
ImageQuant software. The same experiment was repeated three times. 100% incorporation was set to 
highest incorporation value observed (40min, +Top1 in all experiments). Relative incorporation was 
calculated at each time point and the average values from the three experiments were plotted in the 
graph. The difference in incorporation between +TopI and –TopI (Δ values) was calculated for each 
time point of each experiment. Average for Δ values and standard deviations (in brackets) are indicated 
at each time point, showing statistically significant increase of incorporation due to in vitro Top1 
treatment. This experiment was performed by Yoshi Hashimoto in the lab of Vincenzo Costanzo 
at Cancer Research UK. 
 
To assess whether accumulation of topological stress might contribute to impair fork 
progression upon CPT/TPT treatment, we took advantage of the biochemical 
versatility of the Xenopus egg extract system and of our ongoing collaboration with 
the group of Dr. Vincenzo Costanzo at Cancer Research UK. We initially let sperm 
nuclei replicate upon Top1 inhibition by TPT addition. After isolation, the nuclei 
were treated with calf thymus Topoisomerase I to partially release the accumulated 
topological tension and re-incubated in the presence of TPT, in conditions where 
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further DNA synthesis solely depends on elongation of already active forks. This was 
achieved by inhibition of further origin licensing. We observed that in vitro relaxation 
by purified Top1 could assist further fork progression in the presence of TPT, as 
detected by significant and reproducible increase of incorporation of radiolabeled 
nucleotides at all time points along the kinetic (Fig.2.16). 
 
2.10 PARP inhibition prevents fork slowdown upon Top1 poisoning. 
The poly (ADP-ribose) polymerase (PARP) family has been previously involved in 
the cellular response to Top1 inhibitors assisting Top1cc repair by largely elusive 
mechanisms (Curtin, 2005). PARP1 was previously shown to prevent fork slowdown 
upon CPT treatment (Sugimura et al., 2008), although it does not affect the number of 
primary lesions induced by Top1 poisons (Top1ccs) (Zhang et al., 2011). Due to the 
implications of PARP in Top1 poisoning, we set out to investigate a possible role for 
PARP in the observed molecular responses to Top1 poisons. We started by 
reproducing in U2OS cells the effects on fork progression observed upon CPT 
treatment in Hela and DT40 cells (Sugimura et al., 2008). 
                              
Fig.2.17. Single-molecule analysis of replication fork progression in U2OS cells upon Top1 and/or 
PARP inhibition. Relative length of DNA tracts synthesized after mock (NT) or CPT treatment 
(25nM) [IdU, green]. At least 100 tracts were scored for each dataset. 10μM Olaparib was optionally 
added 2h before CldU labelling and maintained during labellings. Whiskers indicate 10-90 percentile. 
T test according to Mann-Whitney, results are ns not significant, *** p ≤ 0.0001. 
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In agreement with that publication, we also found that fork slowdown mediated by 
Top1 poisoning is completely abolished upon PARP inhibition by Olaparib 
(Fig.2.17). These data suggest that PARP plays a role in controlling fork progression 
in response to CPT treatments and its inhibition leads to unrestrained fork progression 
upon Top1 poisoning. 
 
2.11 PARP inhibition reduces the frequency of fork reversal upon Top1 
poisoning. 
Since our data confirmed that fork slowdown upon Top1 inhibition is mediated by 
PARP, we investigated whether fork reversal upon Top1 inhibition was also 
dependent on PARP activity. PARP inhibition by NU1025  markedly reduced (9-fold) 
RF frequency in TPT-treated sperm DNA replicating in Xenopus egg extracts 
(Fig.2.18). Similarly, PARP inactivation by Olaparib reduced RF frequency by 7-fold 
in CPT-treated U2OS cells (Fig.2.18). To exclude unspecific effects of PARP 
inhibitors we also analyzed RF frequency upon CPT treatment of MEFs derived from 
PARP1+/+ and PARP1-/- mice. We observed a significant (2-3 fold) reduction in CPT-
induced reversed forks in absence of PARP1. The milder effect observed in PARP1 
knock-out cells compared to PARP inhibitors could be due to the partially redundant 
role of other PARPs in the PARP1-/- background, whereas all PARPs are co-targeted 
by the inhibitors. These results show that, in Xenopus, human and mouse cells, 
effective fork slowing and reversal upon Top1 inhibition require PARP activity. 
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 Fig.2.18. Top1 inhibition induces PARP-mediated replication fork reversal. Frequency of fork 
reversal in Xenopus egg extracts (50µM TPT ± 200µM NU1025), U2OS cells (25nMCPT ± 10µM 
Olaparib) and CPT-treated (25nM) PARP1+/+ and PARP1-/- MEFs by EM. In brackets, the number of 
analyzed molecules. Similar results were obtained in at least one independent experiment. 
 
3.12 PARP inhibition leads to defective bulk DNA synthesis and increased DSB 
formation upon Top1 poisoning. 
Since PARP activity is required for fork slowdown upon CPT treatments, we next 
investigated its role in bulk DNA synthesis and checkpoint activation. To address this, 
a cell cycle analysis was performed in asynchronous cells treated with CPT and/or 
Olaparib. While Olaparib treatment lead per se to modest checkpoint activation and 
transient delay of cell cycle progression (Fig.2.19A), CPT 25nM treatment markedly 
delayed S phase progression and strongly activated the DNA damage checkpoint 
(Fig.2.19A-B), confirming our results in the synchronization setting (Figs.2.10 and 
Fig.2.13). Simultaneous Top1 and PARP inhibition (CPT + Olaparib) further delays S 
phase completion, retaining a strong activation of the DNA damage checkpoint (both 
pChk1 and pATM) (Fig2.19A-B). Considering that PARP inactivation prevents fork 
slowdown by CPT treatment (Fig.2.17 and Sugimura et al., 2008), these data suggest 
that slower bulk DNA synthesis rates and consistent checkpoint activation could 
result from unrestrained fork progression resulting in DSB. 
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 Fig.2.19. Combined effects of Top1 and PARP inhibition on cell cycle progression and checkpoint 
activation. Asynchronously growing U2OS cells were treated with 10µM Olaparib, 25nM CPT or both 
for the indicated time points. A) Analysis of cell cycle progression by flow cytometric detection of 
DNA content (Propidium Iodide). B) Western blot analysis of checkpoint activation (pATM and 
pChk1). TFIIH, loading control. 
 
We thus tested the hypothesis that, upon PARP inhibition, DSB could be detected also 
upon CPT treatment at low (nM) concentrations. Indeed, PFGE analysis revealed that 
PARP inhibition by Olaparib in U2OS lead to detectable amounts of DSB upon CPT 
treatments that showed no detectable (25nM) or only barely detectable (100nM) DSB 
in control conditions (Fig.2.20).  As we did for our EM analysis (Fig.2.18), to rule out 
possible aspecific effects of PARP inhibitors, similar PFGE experiments were done in 
PARP1 deficient MEFs.  Again, similarly to what we found for fork reversal 
(Fig.2.18), genetic PARP1 inactivation (PARP1-/- MEFs) led to a mild, but significant 
DSB accumulation upon 100nM CPT treatment (Fig.2.20). 
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 Fig.2.20. PARP inactivation in U2OS and MEFs leads to DSB formation at minimal CPT doses. 
(A) PFGE analysis for DSB detection upon 4h CPT treatments of U2OS cells, PARP1+/+and PARP1-/- 
MEFs ± 10µM Olaparib. The graph integrates results from three independent experiments and shows 
DSB levels relative to untreated conditions (dashed line). 
 
To further confirm this observation, we also followed DSB formation by 
colocalization of the DSB repair factors γ H2AX and 53BP1 in nuclear foci. As 
expected, Olaparib treatment per se had no detectable effect on the detection of the 
two markers, while γH2AX and 53BP1 showed a high degree of colocalization in IR-
induced foci (Fig.2.21A). A high number of γH2AX foci were already detectable in S 
phase cells at minimal (25nM) CPT doses, but only a minor fraction of them 
colocalized with 53BP1 (Fig.2.21B). Notably, PARP inhibition in CPT-treated cells 
did not significantly change the number of γH2AX-positive cells or the total number 
of γH2AX foci, but led to a higher degree of colocalization of γH2AX and 53BP1 
foci upon nM CPT treatments (Fig.2.21B-C). Lethal CPT treatments (≥1μM) lead to 
more heterogeneous patterns, most probably resulting from replication independent 
effects (Fig.2.21C). These data suggest that PARP activity limits DSB formation upon 
Top1 poisoning and that most γH2AX foci formed upon sublethal CPT treatments 
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identify structures different from DSB. 
 
Fig.2.21. IF analysis of DSB markers (γH2AX and 53BP1) upon PARP inactivation at minimal 
CPT doses. (A) Representative pictures of U2OS cells treated for 1h with CPT, as indicated, ±10µM 
Olaparib, and co-stained for γH2AX and 53BP1. (B) The graph shows the average number of γH2AX 
foci per cell and the average fraction (and standard deviations) of γH2AX foci colocalizing with 
53BP1. (C) Cells were treated as in (A) and scored for the DNA damage marker γH2AX. The gray 
dotted line indicates the percentage of cells in S-phase, as determined by an independent EdU 
incorporation experiment. At least 100nuclei were analyzed in all conditions; positive cells had >5 foci 
per nucleus. IR (positive control for γH2AX) : U2OS cells 1h after 10Gy irradiation.  
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Table2.1. List of chromosomal regions showing CPT-induced fork delay by BrdUChIP-chip 
analysis and their association with centromeres and termination sites. Chromosome numbers, 
extent (kb) of CPT-induced fork delay, corresponding origin of replication and CPT-delayed fork 
positions are shown. “+” indicates the presence of a specific genomic element, such as centromeres 
(CEN) or replication termination regions 
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Additional collaborative results (Steve Fosters and John Petrini; Memorial Sloan 
Kettering Cancer Center, New York, USA) 
 
It was earlier shown that Ku deficiency mitigates the IR sensitivity of mre11Δ strains, 
and that the suppressive effect was outside of G1 cells (Bressan et al., 1999). Loss of 
yKu70 has a similar effect on MMS sensitivity of rad50Δ mutants(Wasko et al., 
2009). Based on these observations, and the observation that the Mre11 complex 
deficiency primarily affects DNA repair by HR (Krogh and Symington, 2004), it was 
hypothesized that Ku complex had an inhibitory effect on HR. Given its role in DSB 
end resection (Mimitou and Symington, 2008; Zhu et al., 2008), we examined effects 
of yKu70 deficiency in mutants with impaired Mre11 nuclease activity (mre11-3) 
upon treatment with CPT. 
2.13 yKu70 deficiency rescues the CPT sensitivity of mre11-3 mutants, by an 
Exo1-mediated mechanism. 
 
Fig.2.22 yKu70 deficiency rescues the sensitivity of mre11 nuclease mutants to CPT, by an Exo1-
mediated mechanism (Experiments performed by Steve Fosters, MSKCC, NY). Cultures were 
serially diluted 5-fold, spotted onto YPD containing the indicated doses of CPT and grown at 30°C for 
2.5 days. (A) yKu70 deficiency rescues the CPT sensitivity of mre11-3 mutants.  DNL4 deletion does 
not rescue the CPT sensitivity of mre11-3 mutants. (B) Exo1 deficiency abolishes the yku70Δ-
dependent rescue of mre11-3 CPT sensitivity. 
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To investigate how CPT treatment affects survival of different yeast strains, serial 
dilutions of yeast cultures were spotted on YPD plates containing different CPT doses 
(Fig.2.22A). 10µM CPT treatments led to high degree of sensitivity in mre11-3 cells. 
mre11-3 yku70Δ double mutants, on the other hand exhibited reduced sensitivity to 
CPT (Fig2.22A). The rescue of CPT sensitivity was not attributable to yku70Δ -
associated defects in NHEJ, as DNA ligase IV deficiency in mre11-3 mutants did not 
alter CPT sensitivity at any dose tested (Fig.2.22A). These data indicate that yKu70 
has an NHEJ independent function that increases the toxicity of CPT-induced DNA 
lesions. 
Furthermore, it was found that Exo1 deficiency abolished yku70Δ-dependent 
suppression of mre11-3 CPT sensitivity (Fig.2.22B), as shown by higher CPT 
sensitivity of mre11-3 exo1Δ yku70Δ triple mutants compared to either mre11-3 
yku70Δ or mre11-3 cells. In addition, Exo1 deficiency partially increased the CPT 
sensitivity of both mre11-3 and yku70Δ single mutants, supporting the view that DNA 
end resection by Exo1 is the basis of the yku70Δ rescue (Fig.2.22B). These data 
suggest that Ku inhibits the ability of Exo1 to act at DNA ends and that this Exo1 
activity becomes crucial for CPT resistance in the absence of Mre11 nuclease activity. 
 
2.14. EXO1 mediated yku70Δ-dependent suppression does not alter  the 
frequency of fork reversal but leads to aberrant DNA structures. 
Since treatment with CPT induces rapid fork reversal in yeast, we hypothesized that 
Mre11 could be responsible for mediating resection of the regressed arm, to promote 
fork restart. According to this model, in the absence of Mre11-resection, , Ku70 
would bind to the regressed arm and stabilize the structure, aborting replication 
intermediates and leading to increased CPT cytotoxicity. In the absence of both 
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Mre11 nuclease activity and Ku, Exo1 may gain access to the fork and provide an 
alternative nuclease activity to promote reversed fork restart. To test this hypothesis, 
we treated wt, mre11-3, yku70Δ, mre11-3  yku70Δ and mre11-3  yku70Δexo1Δ cells 
with CPT  and analyzed their RIs by EM. 
Analysis of RIs revealed no significant difference in the frequency of reversed  
 
      
Fig.2.23 Similar frequency of CPT-mediated fork reversal in wt, mre11-3, yku70Δ, mre11-3  
yku70Δ and mre11-3  yku70Δexo1Δ cells.  Preliminary data for frequency of fork reversal in Wt, 
mre11-3, yku70Δ, mre11-3  yku70Δ and mre11-3  yku70Δexo1Δ  cells treated with CPT 50µM. At least 
50 molecules were analyzed for each strain. 
 
 fork formation in all the strains with the exception of mre11-3 yku70Δexo1Δ 
(Fig.2.23). mre11-3 yku70Δexo1Δ showed a lower frequency of reversed fork 
formation than the other strains, but this analysis needs to be completed by increasing 
the total number of RIs analyzed in order to assess whether this difference may be 
statistically significant. 
Furthermore, all strains bearing the mre11-3 mutation showed frequent aberrant DNA 
structures characterized by increased numbers of "ramifications" on the DNA, that 
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cannot be attributed to any recognizable molecular pattern typically observed at RIs 
(Fig.2.24A-B). This pathological phenotype was never previously observed at RIs in 
response to different kinds of replication stress and is a relatively rare event also in 
CPT-treated wt and yku70Δ cells (Fig.2.24B). Therefore, these unusual intermediates 
may contribute to explain the strong CPT-sensitivity associated with the mre11-3 
mutation (Fig.2.24A). The frequency of these unusual ramified molecules reaches 
approximately 50% of the total number of analyzed molecules in mre11-3 and mre11-
3 yku70Δ exo1Δ, the two CPT-hypersensitive strains. Interestingly, although mre11-3  
yku70Δ cells also showed these molecules, their overall frequency (approximately 
30%) was reduced compared to mre11-3 and mre11-3 yku70Δexo1Δ mutants 
(Fig.2.24B).. A similar trend was also observed considering the number of 
ramifications in individual DNA molecules, with the mre11-3 and mre11-3  
yku70Δexo1Δ strains showing the highest number of ramifications/molecule, 
compared to mre11-3  yku70Δ. 
It is currently unclear how these aberrant molecules are formed and what is their 
relationship with the observed, CPT-induced reversed forks. One interesting 
hypothesis to pursue in the future is that these molecules result from restart of forks 
that had been previously, transiently reversed. In this scenario, the observed reversed 
forks may mark transiently stalling at the specific time chosen for DNA extraction, 
which is not necessarily expected to change in the different genetic backgrounds. On 
the other hand, the aberrant "ramified" molecules may reflect failing attempts to 
restart forks that had been stalled and reversed at an earlier time point. In this respect, 
the lower penetrance of this phenotype in mre11-3  yku70Δ cells may result from 
more effective, Exo1-mediated processing of these structures, which could eventually 
result in restored genome integrity and contribute to the CPT-resistance observed in 
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this genetic background. Additional work will be required to test this hypothesis and 
fully understand the surprising molecular phenotypes observed in these strains upon 
Top1 inhibition. 
 
 
Fig.2.24 Top1 inhibition results in aberrant DNA structures in mre11-3, mre11-3  yku70Δ and 
mre11-3  yku70Δexo1Δ cells. A) Representative electron micrograph of an aberrant RI observerd in 
CPT-treated mre11-3 cells. (B) Statistical analysis of the percentage of "ramified" molecules in Wt, 
mre11-3, yku70Δ, mre11-3  yku70Δ and mre11-3  yku70Δexo1Δ  cells treated with CPT 50µM. At least 
50 molecules were analyzed for each strain. (C) Statistical analysis of the number of 
ramifications/molecule in the strains as in (B) 
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Genomic DNA is highly vulnerable to mutagenesis during DNA rep-
lication as replication fork progression is frequently impaired by DNA 
lesions caused by exogenous or endogenous factors such as ultraviolet 
light and reactive oxygen species. Many redundant pathways preserve 
fork integrity in the presence of DNA damage1,2. This prevents the 
lethal effects caused by the complete collapse of replication forks lead-
ing to double-strand breaks (DSBs). DNA lesions can be bypassed 
by error-prone translesion synthesis polymerases such as Pol η or 
Pol ζ3. This polymerase switching requires monoubiquitination of 
proliferating cell nuclear antigen (PCNA) at Lys164 mediated by the 
Rad6–Rad18 complex4.
Another pathway called template switching ensures continuous, 
error-free replication across DNA lesions by using newly synthesized, 
undamaged daughter strand as a template, instead of the damaged 
parental strand, so as to bypass the lesion. Template switching has 
been proposed to involve fork regression by annealing of nascent 
strands at the fork1,2.
Strand invasion of the paused nascent strand into the sister 
chromatid to continue replication is also possible. This pathway 
requires homologous recombination proteins such as Rad51, the 
eukaryotic ortholog of RecA in Escherichia coli, which has a cen-
tral role in homologous recombination during meiosis as well as 
during DSB repair5.
Rad51 is not essential in yeast, but it is required for cell prolif-
eration in vertebrates6,7. This suggests that in vertebrates Rad51 has 
indispensable roles not only in meiotic chromosomal recombination 
and segregation but also in the normal cell cycle. A role for Rad51 
in S phase has been postulated8–10. However, it is unclear whether 
Rad51 is solely required to repair DSBs that spontaneously arise 
 during the normal cell cycle, or whether it has an additional replicative 
role beyond DSB repair.
The pathways described above (translesion synthesis, template 
switching and homologous recombination), which are involved in 
postreplication repair, could operate at the fork to ensure its progres-
sion through DNA damage. However, these pathways might not be 
necessary for the fork progression itself and could instead be deployed 
to repair gaps behind the fork11. This issue is only poorly understood 
because there is not enough structural information available about 
replication forks and their surrounding regions. A few studies have 
highlighted DNA gaps behind forks in the presence of obstacles to 
replication fork progression12,13. Rad51 has been suggested to mediate 
two distinctive pathways: one promotes replication restart after short 
exposure to hydroxyurea, whereas the other promotes repair of forks 
completely collapsed by prolonged exposure to hydroxyurea14. The 
former pathway is also supported by evidence showing that nucleotide 
excision repair (NER) mutant cells irradiated with ultraviolet light 
accumulate collapsed forks, which are mainly rescued by a Rad51-
dependent pathway to enable restart15. These results suggest that 
Rad51 functions both at forks and behind them.
In this study, we established a cell-free system based on X. laevis 
egg extract to study the role of Rad51 during DNA replication. Using 
EM-based analysis to directly observe replication fork structures and 
a biochemical assay to detect DNA gaps, we have discovered that 
Rad51 is required to prevent formation of DNA gaps at forks and 
behind them. DNA gaps behind forks are suppressed by inhibition of 
Mre11 nuclease activity, indicating that Rad51 protects nascent DNA 
from nuclease-mediated degradation.
RESULTS
Rad51 associates with replicating chromatin
Xenopus laevis egg extracts can be used to biochemically character-
ize essential DNA repair proteins involved in DNA replication16–19. 
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Rad51 protects nascent DNA from Mre11-dependent 
degradation and promotes continuous DNA synthesis
Yoshitami Hashimoto1, Arnab Ray Chaudhuri2, Massimo Lopes2 & Vincenzo Costanzo1
The role of Rad51 in an unperturbed cell cycle has been difficult to distinguish from its DNA repair function. Here, using EM 
to visualize replication intermediates assembled in Xenopus laevis egg extract, we show that Rad51 is required to prevent 
the accumulation of single-stranded DNA (ssDNA) gaps at replication forks and behind them. ssDNA gaps at forks arise from 
extended uncoupling of leading- and lagging-strand DNA synthesis. In contrast, ssDNA gaps behind forks, which are prevalent 
on damaged templates, result from Mre11-dependent degradation of newly synthesized DNA strands and are suppressed by 
inhibition of Mre11 nuclease activity. These findings reveal direct roles for Rad51 at replication forks, demonstrating that  
Rad51 protects newly synthesized DNA from Mre11-dependent degradation and promotes continuous DNA synthesis.
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To verify whether Rad51 has a role in DNA replication, we moni-
tored chromatin binding of X. laevis Rad51, which is highly conserved 
among vertebrates and is present at 20 nM in X. laevis egg extract 
(data not shown). We also monitored the binding of other replica-
tion factors during DNA replication on undamaged and damaged 
templates. We found that Rad51 binds to chromatin during DNA 
replication (Fig. 1a). Its binding is impaired by inhibition of replica-
tion origin assembly, induced by supplementing extract with geminin, 
which prevents minichromosome maintenance (MCM) helicase 
loading20 (Fig. 1 and Supplementary Fig. 1a), and by inhibition of origin 
firing, achieved by treating extracts with cyclin-dependent kinase 
inhibitor p27 (ref. 21; Fig. 1 and Supplementary Fig. 1b). Rad51 
binding in the presence of agents that stall replication forks, such as 
aphidicolin, ultraviolet light and methylmethanesulfonate (MMS), 
was also sensitive to geminin and p27 (Fig. 1 and Supplementary 
Fig. 1b). In contrast, the induction of DSBs mediated by EcoRI endo-
nuclease, revealed by the presence of γH2AX, was resistant to geminin 
and p27 treatments (Fig. 1 and Supplementary Fig. 1a,b). These 
data indicate that a fraction of Rad51 binding to chromatin takes 
place after replication forks have been established and depends partly 
on the number of active replication forks. Consistent with this, the 
amount of Rad51 bound to chromatin was linearly correlated with the 
levels of Psf2 and therefore with the number of active forks (Fig. 1a). 
Accordingly, the relative amount of Rad51 per fork, calculated by 
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Figure 1 Rad51 binding to undamaged and damaged chromatin during DNA replication. (a) Time course of chromatin association of Rad51 and the 
indicated replication proteins. Immunoblotting was carried out for chromatin fractions incubated in 30 μl egg extract for indicated times in presence or 
absence of aphidicolin (Aph, 10 μg ml−1) or EcoRl (0.1 unit μl−1). Where indicated, sperm nuclei were treated with 1,000 J m−2 ultraviolet (UV) light 
and 1% (v/v) MMS, respectively. 0.5 μl egg extract (ext) was used as control. (b) Effect of BRC4 on chromatin association of Rad51 and replication fork 
proteins. Immunoblotting was carried out for chromatin fractions incubated in 25 μl of egg extract for 60 min in the presence of 0.5 mg ml−1 GST or 
0.5 mg ml−1 GST-BRC4. Sperm nuclei were incubated in extracts that were untreated (−) or incubated with 50 μg ml−1 aphidicolin. Where indicated 
sperm nuclei were irradiated with ultraviolet light at 1,000 J m−2 or treated with 1% (w/v) MMS before the incubation in egg extract. 1 μl extract (ext) 
was used as control. (c) Quantification of Rad51 bound to damaged and undamaged chromatin in the presence (+geminin) or in the absence (−geminin) 
of 160 nM geminin, and in the presence (+p27) or absence (−p27) of 40 μg ml−1 p27 recombinant protein. Graph, average relative values of several 
repeated experiments taking as reference the amount of Rad51 bound to undamaged chromatin in the presence of geminin or p27 (C, control). Error 
bars, ± s.d. Representative immunoblots are shown in Supplementary Figure 1a–b.
Figure 2 Rad51 and PCNA modifications in 
DNA replication and ssDNA gap accumulation. 
(a) Rad51 and PCNA requirement for replication 
of untreated and MMS-treated DNA. Replication 
products resolved on 1% (w/v) alkaline gels 
obtained by incubating sperm nuclei in 10 μl 
egg extract with [α-32P]dATP for the indicated 
times in presence or absence of 0.7 mg ml−1 
GST or GST-BRC4 and MMS (− or +), and  
0.2 mg ml−1 of recombinant wild-type (WT) 
or mutated (K164R) PCNA. (b) Quantification 
of signal intensities in a. Experiments shown 
represent a typical result. (c) Gap-labeling 
procedure using T4 DNA polymerase. 
Replicating genomic DNA was isolated and used 
as a template for gap-filling assay using T4 DNA 
polymerase. The labeled nascent molecules 
extended by T4 were then resolved on alkaline 
agarose gel. (d) Untreated (−MMS) and MMS-
treated (+MMS) sperm nuclei were incubated 
in 10 μl of egg extract in the presence of GST 
or GST-BRC4 for 60 min (lanes 1–4). Untreated 
sperm nuclei were incubated for 40, 60 or  
80 min in the presence of wild-type (WT) PCNA 
or PCNA K164R (lanes 5–10). Genomic DNA 
was isolated and subjected to the gap-labeling reaction followed by autoradiography. Exposure times are equivalent for the two gels, although kinetic 
profile starts at 40 min in lanes 5–10. Graph, relative fold increase in optical density for each lane taking as reference untreated chromatin recovered  
at 60 min. Experiment shows a typical result.
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determining the ratio between Rad51 and Psf2 signal intensities at 
40 min, was 0.35 for untreated extracts and 0.57, 0.55 and 0.51 for 
extracts treated with aphidicolin, ultraviolet light and MMS, respec-
tively. Overall, these data suggest that in addition to its role in DSB 
repair, Rad51 is involved in DNA replication.
Effects of impaired Rad51 chromatin binding
To study the replication function of Rad51, we inhibited Rad51 bind-
ing to chromatin using recombinant human BRC4 (one of eight BRC 
motifs of BRCA2 that has a strong affinity for Rad51; ref. 22) fused to 
glutathione S-transferase (GST), GST-BRC4, which efficiently binds 
X. laevis Rad51 even at high salt concentrations (Supplementary 
Fig. 1c). GST-BRC4 completely suppressed Rad51 chromatin bind-
ing but did not impair the binding of replication proteins such as 
Mcm2, PCNA, Pol α, Cdc45 and Psf2 of the GINS complex (Fig. 1b). 
This indicates that Rad51 is not required for the assembly of repli-
cation proteins onto chromatin. Unlike the BRC4 peptide used by 
Carreira et al.23, the peptide used here (residues 1511–1579 of 
BRCA2) does not promote Rad51 binding to ssDNA in vitro. We used 
the minimal GST-BRC4 concentration required to effectively suppress 
Rad51 binding to chromatin (data not shown). As at this concentra-
tion GST-BRC4 suppressed both ssDNA and double-stranded DNA 
(dsDNA) binding of Rad51 (Supplementary Fig. 1d), we could not 
determine whether the effects we observed on chromatin derive mainly 
from the inhibition of Rad51 binding to ssDNA or to dsDNA.
To determine the role of Rad51 in DNA synthesis, we analyzed nas-
cent ssDNA molecules recovered from X. laevis egg extracts in which 
Rad51 chromatin binding was inhibited by GST-BRC4. As redundant 
Figure 3 Rad51 is required to prevent replication fork uncoupling and ssDNA accumulation on damaged and undamaged templates. (a) Electron 
micrograph (and schematic drawing) of a representative replication intermediate isolated from sperm nuclei incubated in GST-BRC4 treated extracts. 
Black arrows, ssDNA regions at the replication fork. White arrows, ssDNA gaps along the replicated duplexes (internal gaps). (b) Statistical distribution 
of internal gaps in the analyzed population of molecules. Number of molecules analyzed is in parentheses. (c) Electron micrograph of a representative 
replication intermediate showing an extended ssDNA region at the fork (arrow). (d) Statistical distribution of ssDNA length at replication forks isolated 
in the indicated conditions. Number of forks analyzed is in parentheses.
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postreplication repair pathways such as translesion synthesis could 
mask the role of homologous recombination in replication fork pro-
gression, we also attenuated translesion synthesis using a recombinant 
mutant PCNA (PCNA K164R) that cannot be ubiquitinated24 and 
therefore does not fully support binding of translesion Pol η to chro-
matin (Supplementary Fig. 1e). DNA replication efficiency was not 
affected by inhibition of Rad51 chromatin binding and/or impairment 
of translesion synthesis (Fig. 2a,b, lanes 1–4). Furthermore, after DNA 
damage induced by MMS, the efficiency of DNA replication decreased 
(Fig. 2a,b, lanes 5–8) owing to hindrance of fork progression and 
checkpoint-mediated inhibition of further origin firing25. However, 
residual DNA replication was not affected, and nascent DNA strands 
matured with similar kinetics in the absence of Rad51 and/or PCNA 
ubiquitination (Fig. 2a, lanes 5–8). Collectively, these data show 
that Rad51 is dispensable for fork progression even with impaired 
translesion synthesis.
Accumulation of ssDNA gaps in the absence of Rad51
Having ruled out a role in replication fork progression for Rad51, 
we investigated subtler genomic defects to elucidate the function of 
Rad51 in DNA replication. Chicken DT40 cells deficient in Rad51 
accumulate ssDNA gaps26 and DSBs7 after one or a few cell cycles, 
respectively. However, it is unclear whether such lesions arise directly 
from defects in the DNA replication process or in DNA repair. We 
did not detect formation of DSBs after one round of DNA replica-
tion in the absence of Rad51 bound to chromatin (data not shown). 
However, using a gap-filling assay27 based on T4 DNA polymerase, 
which has primer extension and translesion synthesis28 but not strand 
displacement activities (Fig. 2c,d), we observed a five-fold increase 
of labeled ssDNA molecules on undamaged (>10 kilobases (kb)) and 
MMS-damaged templates (0.5–10 kb) in extracts treated with GST-
BRC4, confirming that although DNA replication is not inhibited, 
ssDNA gaps accumulate in the absence of Rad51 bound to chromatin 
(Fig. 2d, lanes 1–4).
We also monitored the accumulation of ssDNA gaps in extracts 
deficient in translesion synthesis, which helps prevent the accu-
mulation of ssDNA gaps after damage by ultraviolet light. As we 
expected, we observed increased ssDNA gaps on damaged templates 
in the absence of translesion synthesis (Supplementary Fig. 2), and 
we observed no additive effects in the presence of both GST-BRC4 
and PCNA K164R, suggesting that Rad51 and translesion synthesis 
operate in the same gapped regions. These observations are con-
sistent with the postreplication repair model, in which replica-
tion forks proceed past DNA damage, leaving unreplicated ssDNA 
gaps that are subsequently sealed by translesion synthesis and/or 
homologous recombination11,29.
However, in contrast to our findings for Rad51, translesion syn-
thesis impairment alone did not induce noticeable accumulation of 
ssDNA gaps on undamaged templates (Fig. 2d, lanes 5–10). This 
indicates that Rad51 but not translesion synthesis prevents the accu-
mulation of such lesions on undamaged templates and suggests that 
Rad51 has a specific role in preventing replication-associated DNA 
lesions in addition to its role in DNA repair.
Notably, an excess of recombinant X. laevis Rad51 added back to 
egg extract containing GST-BRC4 suppressed the accumulation of 
ssDNA gaps (Supplementary Fig. 3). We obtained similar results by 
adding recombinant human Rad51, but not by adding an irrelevant 
protein such as GST (data not shown). These control experiments 
confirm the specificity of GST-BRC4 effects on Rad51.
Replication intermediate structure in the absence of Rad51
To investigate Rad51 function during DNA replication, we carried 
out in vivo EM analyses of genomic replication intermediates cou-
pled to psoralen cross-linking, according to established methods and 
procedures30 that we adapted to sperm nuclei replicated in X. laevis 
egg extracts, with and without DNA damage (see Online Methods). 
Under standard enrichment procedures used for analogous analysis 
in yeast and mammalian cells12,30,31, EM samples showed a high fre-
quency of replication intermediates. After we identified replication 
intermediates (see Online Methods), we assessed the frequency and 
length of ssDNA regions by detecting local differences in filament 
thickness. Although ssDNA stretches can also be detected by EM 
using single strand–binding proteins, short ssDNA stretches do not 
consistently assemble nucleoprotein complexes and may escape EM 
detection12. Instead, we assessed DNA thickness along replicating 
molecules to score the number and size of ssDNA gaps, focusing on 
relative differences from control samples under the same experi-
mental conditions12. We found that, during DNA replication, 60% 
of replication intermediates isolated from extracts in which Rad51 
chromatin binding was inhibited showed at least one ssDNA gap 
behind the replication fork (internal gaps, Fig. 3a,b), a rare event in 
control extracts. Whereas control extracts treated with MMS accu-
mulated relatively few internal gaps, Rad51-depleted extracts treated 
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Figure 4 Accumulation of ssDNA gaps in the absence of Rad52 and 
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with MMS had gaps in 80% of replication intermediates, and more 
than two gaps on the same fork in 30% of replication intermediates 
(Fig. 3b). The size of the internal gaps is rather heterogeneous, but 
in most cases <300 nucleotides (nt). Even though Rad51-depleted 
extracts had more gaps than the control extracts, the size distribution 
of the gaps was similar (Supplementary Fig. 4). Such ssDNA gaps 
behind replication forks have been observed and related to 
repriming events downstream of lesions on 
the template12. Consistently, their persistence 
in cells deficient in homologous recombination 
and translesion synthesis has been attributed 
to defects in postreplication repair.
As repriming was shown to result from 
extended uncoupling of leading- and lagging-
strand synthesis12, we analyzed replication 
intermediates for the presence of ssDNA 
regions directly at the fork. Small ssDNA 
regions (<200 nt) are often detectable by this 
assay at unperturbed replication forks, mark-
ing discontinuous lagging strand synthesis12. 
Notably, even without exogenous DNA 
damage, ~50% of replication intermediates 
in Rad51-depleted extracts had a markedly 
long (>200 nt) ssDNA region at the fork 
(Fig. 3c,d), suggesting frequent uncoupling 
of leading- and lagging-strand synthesis. In 
many cases, we detected ssDNA regions of 
up to 800 nt (Fig. 3c). As has been shown for 
yeast12, MMS treatment, even at concentra-
tions that markedly affect fork progression 
(Fig. 2), had limited effects on leading- and 
lagging-strand uncoupling, as 80% of control 
replication intermediates had ssDNA regions 
at the fork of <200 nt in the presence of MMS 
(Fig. 3d). This suggests that the mechanism 
producing ssDNA at forks is distinct from the 
one responsible for ssDNA-gap formation behind them in the presence 
of MMS-induced DNA damage. Notably, we also observed that ssDNA 
tracts accumulated during DNA replication at forks and behind them 
in yeast rad52Δ mutants (Fig. 4) in which Rad51 chromatin loading is 
impaired32,33. We obtained similar results with yeast rad51Δ mutants, 
although the accumulation of post-replicative ssDNA gaps was less pro-
nounced than in rad52 cells. This probably reflects the contribution of 
S. cerevisiae Rad59, a Rad52 paralog that mediates Rad51-independent 
recombination mechanisms34. Overall, these data indicate that the 
function of Rad51 to prevent the accumulation of ssDNA gaps is con-
served across different species.
Mre11-dependent formation of ssDNA gaps behind forks
We then tested whether ssDNA accumulation arises from nuclease-
dependent degradation of newly synthesized DNA. To this end, we 
treated extracts with mirin, which specifically inhibits the activity 
of Mre11 (ref. 35), a major nuclease present at replication forks17,36. 
Notably, mirin prevented accumulation of detectable ssDNA gaps 
behind forks formed upon suppression of Rad51 binding to DNA 
(Fig. 5a). In contrast, Mre11 inhibition by mirin did not suppress 
accumulation of ssDNA at forks (Fig. 5b). EM analysis was more 
useful in assessing the effects of mirin and Rad51 inhibition than 
the gap-filling assay, as this could not discriminate between ssDNA 
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Figure 6 A model for possible roles of Rad51 during DNA replication. See text for explanation.  
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at forks and behind them. However, consistent with the EM analysis, 
mirin substantially lowered the number of gaps detected with the 
gap-filling assay (Supplementary Fig. 5). In this assay, the effect is 
more noticeable with MMS treatment, in which the majority of the 
labeled fragments result from ssDNA gaps behind the fork. These 
observations indicate that ssDNA gaps behind forks are due to Mre11-
dependent degradation of nascent DNA in the absence of Rad51. 
ssDNA gaps at forks, instead, arise independently from Mre11, either 
through processing by a different nuclease or solely from a defect in 
DNA synthesis.
DISCUSSION
The role of recombination factors in DNA replication has been pos-
tulated in the past. However, direct demonstration of this function 
has been impeded by the lack of an experimental system to directly 
address the function of recombination proteins during DNA repli-
cation. A possible direct role for Rad51 in the replication process 
has been inferred from recent investigations of Rad51 inactivation 
in DT40 cells26. Consistent with this, we also observed ssDNA gap 
 accumulation at forks and behind them in yeast cells lacking Rad51 
and in Rad52-deficient cells in which Rad51 function is impaired32,33. 
Rad51 foci can be observed during unperturbed S-phase progression 
in cultured mammalian cells37,38. Rad51 also mediates restart of tran-
siently stalled forks, but this function is not linked to foci formation 
or to its standard role in DSB repair34.
Although all these observations suggest that a replicative function 
of recombination factors could be well conserved among eukary-
otes, they cannot effectively distinguish between a replicative and 
DNA repair function of Rad51. The accumulation of DNA lesions in 
Rad51-defective cells may depend on defective repair of DNA lesions 
accumulated after one or few cell cycles, or upon short genotoxic 
treatments. However, our results on X. laevis egg extracts now dis-
criminate Rad51 function during DNA synthesis in the presence and 
absence of exogenous DNA lesions, combining selective Rad51 deple-
tion just before one round of DNA replication and direct visualization 
of replication intermediates.
Our data suggest a dual role for the recombination factor Rad51 
during DNA replication: restoring coupling of uncoupled leading- and 
lagging-strand synthesis and protecting nascent DNA from nucleo-
lytic degradation (Fig. 6). Our observations indicate that Rad51 
binding to chromatin during DNA replication might be required 
to limit the size of ssDNA stretches at replication forks (Fig. 6, 
(1)–(3)). We propose that Rad51 is recruited to replication forks 
upon transient uncoupling of the fork at natural impediments and 
consequent accumulation of longer stretches of ssDNA, similarly to 
DSB end resection5. Presumably, Rad51 could be recruited to forks 
undergoing problematic progression. Indeed, transient replication 
fork stalling and uncoupling (Fig. 6, (2)) may be frequent even in 
the absence of exogenous DNA damage and may result from endo-
genous lesions, multiprotein complexes obstructing fork progression 
or sequences prone to form secondary structures. This is reflected 
in the high frequency of pathological ssDNA regions at forks when 
Rad51 binding to chromatin is suppressed during unperturbed DNA 
replication. We envision three possible, non–mutually exclusive sce-
narios for the function of Rad51 in this context (Fig. 6, (3)): (i) Rad51 
may bind extended ssDNA on the blocked leading strand and use its 
strand annealing activity to favor re-annealing with the unwound 
lagging strand, thus counteracting helicase activity and limiting fur-
ther fork uncoupling; (ii) Rad51 binding to the transiently uncou-
pled fork may assist the processivity of the stalled polymerases that 
encounter obstacles to DNA synthesis, such as ssDNA secondary 
structures; and (iii) Rad51 binding may facilitate local recruitment 
of translesion polymerases to promote continuous synthesis across 
endogenous lesions. Notably, translesion polymerases assist DNA 
synthesis on Rad51-dependent recombination intermediates39. In 
addition, RecA, a Rad51-related protein in E. coli, promotes recruit-
ment of translesion polymerases40,41.
At the same time, if persistent uncoupling at bulky lesions leads to 
DNA synthesis repriming, which is especially frequent in the presence 
of exogenous DNA damage (Fig. 6, (4)–(5)), Rad51 binding to the 
resulting ssDNA gaps behind the forks may effectively engage them 
in postreplication repair (Fig. 6, (7)–(8)). According to this model, 
Rad51 binding to replication forks should be transient and selective 
for temporary uncoupled forks, whereas it is probably more stable in 
the presence of permanent DNA lesions. Notably, mammalian Rad51 
paralogs that regulate Rad51 recruitment bind fork structures with 
high affinity and specificity42. Analogously, it is tempting to speculate 
that anti-recombinase helicases such as Srs2, Bloom or R-TEL43,44 
may prevent unscheduled homologous recombination events by 
counteracting inappropriate or permanent Rad51 fork association.
Although a general role for Rad51 in postreplication repair is well 
established, our data show that post-replicative ssDNA gaps not 
bound to Rad51 are prone to extensive Mre11-dependent degrada-
tion (Fig. 6, (9)–(11)). Rad51 may directly counteract Mre11 on these 
ssDNA substrates. We propose that Mre11 and Rad51 are in a dynamic 
equilibrium at ssDNA and counteract each other’s activity through 
a feedback mechanism. On one hand, Mre11-dependent controlled 
resection could be required for Rad51 binding to ssDNA (Fig. 6, (6)), 
similarly to the mechanisms of DSB repair and RecA ssDNA-binding 
in E. coli45. On the other hand, the engagement of these gaps in Rad51-
dependent repair could prevent excessive nucleolytic degradation, 
sequestering the substrates once optimal Mre11-dependent resection 
is achieved (Fig. 6, (7)). In this view, the accumulation of Mre11-
dependent ssDNA gaps behind forks in absence of Rad51 may reflect 
the accumulation of ssDNA intermediates unproductive for strand 
invasion, which may in turn become susceptible to the resection appa-
ratus. The absence of detectable post-replicative ssDNA gaps upon 
mirin treatment and Rad51 depletion may suggest that, in the absence 
of Mre11 activity, nonresected postreplicative ssDNA gaps may be 
below the resolution limit of EM (50–100 nt) and escape detection 
even in the absence of Rad51.
Notably, mutations in SbcD, the putative ortholog of Mre11 in 
E. coli, suppress lethality of RecBCD recombination-defective cells 
in the presence of repetitive palindromic sequences46. The suppres-
sion is due to the inability of SbcD mutant cells to degrade secondary 
structures formed at or behind replication forks47. However, whereas 
SbcD processes secondary structures formed on the template strands, 
the gaps we observe are caused by Mre11-dependent degradation of 
nascent DNA strands. The nuclease activity of Mre11 probably does 
not target parental DNA in eukaryotes. In any case, these observa-
tions suggest that Mre11’s role in processing replication structures 
undergoing recombination events is conserved across species.
METHODS
Methods and any associated references are available in the online 
version of the paper at http://www.nature.com/nsmb/.
Note: Supplementary information is available on the Nature Structural & Molecular 
Biology website.
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ONLINE METHODS
Recombinant proteins and antibodies. Recombinant human Rad51 pro-
teins and the cDNA fragment encoding human BRC4 (residues 1511–1579 of 
BRCA2) cloned into pDONR221 (Invitrogen) were provided by F. Esashi (Oxford 
University). The fragment was then cloned into DEST15, an expression vector 
for GST-tagged recombinant proteins, using the Gateway system (Invitrogen). 
The BRC4-DEST15 plasmid was transformed to BL21-Al cells, and recombinant 
GST-BRC4 protein production was induced by 0.2% (w/v) l-arabinose and 
purified with glutathione–Sepharose 4B according to standard procedures (GE 
Healthcare). Control GST protein was prepared using pGEX 6P-1 empty vector 
(GE Healthcare). The cDNA encoding full-length X. laevis Rad51 was amplified by 
PCR using as 5′ primer (5′-ATGGATCCATGGCCATGCAAGCTCACTATC-3′) 
and 3′ primer (5′-AGAATTCTCAGTCCTTGGCATCTCCCAC-3′) using a 
X. laevis oocyte cDNA library and cloned into pGEX 6P-1. The GST-tagged 
recombinant protein was expressed and purified with glutathione–Sepharose 4B, 
and the GST tag was removed by Prescission Protease (GE Healthcare) treatment 
to obtain an untagged version of Rad51. The pET28-based expression vectors of 
wild-type and mutant (K164R) X. laevis PCNA and the pET21-based expression 
vector of human p27 were provided by H. Ulrich (Cancer Research UK) and 
T. Hunt (Cancer Research UK), respectively, and the recombinant His6-tagged 
proteins were purified with Ni-NTA agarose (QIAGEN). His6-tagged geminin 
was prepared as described19.
Antibodies to Rad51 (14B4, Abcam), Pol α p180 subunit (ab31777, Abcam), 
PCNA (MCA1558, Serotec), Mcm7 (sc-9966, Santa Cruz), γ-H2AX (JW301, 
Upstate) and RPA32 (ab10359, Abcam) were obtained from the indicated pro-
viders. Antibodies to Mcm2, Cdc45, Psf2 and Pol ε p60 subunit were provided 
by H. Takisawa (Osaka University); antibodies to Pol δ p125 subunit and Pol η 
were provided by S. Waga (Japan Women’s University) and M. Akiyama (Nara 
Institute of Technology).
Xenopus laevis egg extracts, chromatin fractions, replication assay and 
gap-filling assay. Interphase egg extracts were prepared as described19. To 
isolate chromatin fractions, usually 4,000 demembranated sperm nuclei per μl 
were incubated in egg extract and diluted with 20 volumes of EB buffer 
(100 mM KCl, 50 mM HEPES-KOH, pH 7.5, 2.5 mM MgCl2) containing 0.2% 
(v/v) Triton X-100 and layered onto 200 μl of a 30% (w/v) sucrose cushion 
made with the same buffer. The chromatin was centrifuged at 10,000g for 5 min 
at 4 °C, washed with 300 μl of EB buffer and centrifuged again at 16,100g for 
1 min. The pellet was suspended with SDS-PAGE sample buffer and analyzed by 
immunoblotting. DNA replication assay with neutral19 and alkaline agarose gel27 
and gap-labeling assay27 were carried out as described. Mirin was provided by 
J. Gautier (Columbia University). ssDNA and dsDNA celluloses were obtained 
from Worthington.
Electron microscopy. Demembranated sperm nuclei (5,000 μl−1) were incubated 
in 1.2–1.5 ml of egg extracts for 45 min (untreated sperm) or for 60 min (0.2% 
(v/v) MMS-treated sperm), diluted with 5 ml of EB buffer, layered onto 2 ml of 
EB buffer plus 30% (w/v) sucrose and centrifuged at 3,000g for 10 min at 4 °C. 
The pellets were resuspended in 600 μl of EB buffer and transferred to a 96-well 
plate (100 μl per well). 4,5′,8-Trimethylpsoralen (TMP) was added at 10 μg ml−1 
to each well. Samples were incubated on ice for 5 min in the dark and irradi-
ated with 366-nm ultraviolet light for 7 min on a precooled metal block. The 
procedure from TMP addition to irradiation with ultraviolet light was repeated 
three more times. Then, the genomic DNA was purified through proteinase K 
(1 mg ml−1) and RNase A (167 μg ml−1) treatment, phenol-chloroform extraction 
and isopropanol precipitation. The purified DNA (20 μg) was digested with NdeI 
endonuclease (100 units) for 5 h, and the replication intermediates were further 
purified on a BND cellulose column30 and were processed for the observation 
with EM as described30. Upon length measurements (ImageJ) of the resulting 
micrographs, DNA replication intermediates were identified by two parameters: 
(i) the presence of at least one fork (three-way junction) and (ii) the presence of at 
least two ‘legs’ of equal length, as expected after restriction digestion of a genomic 
fragment containing a replication fork. The analysis of replication forks derived 
from rad52 mutant cells was carried out as described12. Rad52 and rad51 strains 
have been described12.
See also Supplementary Methods for further details.
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3. DISCUSSION 
Topoisomerase1 is an essential mammalian enzyme. It is also the only known target 
of the alkaloid camptothecin, from which potent, FDA-approved anticancer agents 
irinotecan and topotecan are derived. Furthermore, camptothecin has been regularly 
used in basic research to study replication associated DNA damage. The currently 
accepted mode of action for this class of drugs suggests that the cytotoxicity induced 
by Top1 poisons is due to the formation of replication-dependent DSB. These DSB 
have been proposed to be central, upstream intermediates produced by unavoidable 
collision of replication forks with discontinuities left on the template by Top1 
trapping on the nicked DNA (Top1cc and "run-off" theory, see Introduction). This 
model has been popular for more than 20 years, but has two important implications 
that have not been thoroughly tested experimentally, namely i) that replication fork 
stalling in response to Top1 poisons should be a direct consequence of, and thus 
strictly coupled to, DSB formation; ii) that HR-dependent DSB repair should be 
required for replication fork restart and, if a sufficiently high number of forks is 
affected by Top1cc, even contribute to S phase completion. This long-standing model 
has recently been challenged (Koster et al., 2007), wherein it was shown that Top1 
poisons not only inhibit the religation step of the Top1 "cycle", but also its DNA 
relaxation activity, exerted by controlled rotation of the nicked DNA strand (Koster et 
al., 2005). This leads to the formation of positive supercoils on the DNA, which by 
yet unknown mechanisms would lead to fork stalling and collapse. 
The main objective of this thesis was to address experimentally the implications of the 
"run-off theory" and to search for possible evidence of topological stress on DNA 
replicating in vivo upon Top1 poisoning. 
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Our BrdU ChIP-chip analysis in yeast suggests that Top1 inhibition does not affect 
origin timing and distribution (Fig.2.1), but leads genome-wide to transient replication 
fork slowdown, observable at any time point at about one third of the active 
replication forks (Fig.2.2). This phenomenon is even more dramatic in human cells, 
where the whole population of active forks is persistently slowed down already at the 
lowest tested CPT dose (Fig.2.6), as also supported by the high degree of sister fork 
asymmetry revealed by our DNA fiber analysis (Fig.2.7). Higher CPT doses, 
however, led to only marginal further decrease in fork progression rates, suggesting 
that maximal effects of Top1 poisoning are already visible at nM CPT concentrations, 
which are the only relevant doses to consider for clinical applications (Teicher, 2008) 
and to study physiological cellular responses to Top1 inhibition in basic research 
(O'Connell et al., 2010). Although we did detect the formation of DSB at higher CPT 
doses (≥1uM) in mammalian cells, DSBs could never be detected above background 
levels in cells treated with nM CPT doses (Fig.2.8), that are sufficient to induce a 
marked and global decrease in replication fork progression. Even prolonged 
treatments in pre-synchronized S-phase cells failed to generate detectable DSBs at nM 
CPT concentrations (Fig.2.12). Thus, although we cannot exclude that few breaks 
may escape detection in our PFGE assay, these few DSB (<100/cell;  Fig2.8A-B and 
Ward, 1988) could not account for the marked slowdown observed upon 25nM CPT 
treatment on the entire population of forks [3000-12000/cell; (Ge and Blow, 2010)]. 
Overall, these data strongly suggest that fork slowdown can be largely uncoupled 
from DSB formation upon mild (nM) CPT treatments in human cells. Similarly, in 
yeast cells, although a general DNA damage marker (H2A phosphorylation; Redon et 
al., 2003) and delayed progression of a subset of replication forks are promptly 
detected in S-phase cells upon CPT treatment, the same experimental conditions do 
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not lead to levels of DSBs detectable by PFGE (Fig.2.4), nor to the activation of a 
sensitive DSB marker (Rad53 phosphorylation) in S phase (Redon et al., 2003 and 
Fig.2.5A). These data taken together strongly suggest that Top1 inhibition challenges 
DNA replication forks upstream of DSB formation. Consistent with this hypothesis, 
inactivation of HR-dependent DSB repair in three different eukaryotic systems 
(S.cerevisiae, human cell cultures and Xenopus egg extracts) did not further affect 
bulk DNA replication, nor the rate of fork progression upon Top1 inhibition 
(Fig.2.5B, Fig.2.10A, Fig.2.10C and Fig.2.11). HR seems instead to be required for 
later functions in the cell cycle, as HR defective yeast cells fail to progress to the next 
cell cycle and activate a CPT-induced checkpoint response after completion of bulk 
DNA synthesis (Fig.2.5). Furthermore, HR defects in both yeast and mammalian cells 
(Fig.2.4 and Fig.2.12.) did not lead to increased amounts of breaks even upon 
continuous CPT treatments. On the contrary, our PFGE experiments with CtIP-
depleted mammalian cells even showed reduced amounts of DSBs when compared 
with the Mock treated upon treatment with high doses of CPT (Fig.2.12). Since CtIP 
acts at the very upstream steps of DSB repair (DNA resection), it will be important to 
test whether other HR mutants would show a similar phenotype. It is possible that - in 
the absence of resection - an alternative, faster repair pathway (NHEJ) takes over the 
repair process, reducing the number of detectable DNA breaks upon µM CPT 
treatment. An alternative hypothesis is that CtIP could directly contribute to break 
formation upon CPT treatments by assisting resection of the stalled/reversed forks and 
finally favoring fork collision with Top1ccs. Overall, these data exclude that HR-
dependent DNA repair is strictly required for fork progression and S phase 
completion upon Top1 inhibition, thus contradicting one of the main implications of 
the "run-off theory". 
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 If not collision with Top1ccs and DSB formation, what is then slowing down the 
replication forks upon Top1 inhibition? CPT treatments in all eukaryotic model 
systems resulted in rapid accumulation of reversed forks. Several lines of evidence 
suggest that this could result from accumulation of topological stress ahead of the 
forks upon CPT treatments: 1) Fork reversal was shown as an intermediate formed 
upon accumulation of positive supercoils ahead of the replication fork (Postow et al., 
2001); 2) Top1 poisons impair the relaxation of torsional stress resulting in the 
increase of positive supercoiling on the DNA (Koster et al., 2007); 3) CPT induced 
fork slowing and reversal are frequent at chromosomal locations particularly 
susceptible to topological stress (i.e. termination zones and centromeres)(Fig.2.2C); 4) 
A significant proportion of slow moving forks due to Top1 inhibition in Xenopus egg 
extracts can be assisted in further progression by in vitro resolution of associated 
topological stress (Fig.2.16). 
Although increased supercoiling can per se lead to fork reversal (Postow et al., 2001), 
we show here that PARP activity is required for effective fork reversal in higher 
eukaryotes (Fig.2.18).  We envision several types of mechanism by which PARP 
activity could mediate fork reversal. First, in agreement with early findings (Durkacz 
et al., 1981), PARP could play a direct role in fork reversal by maintaining or 
restoring DNA supercoiling during DNA repair through PARylation of yet unknown 
substrates. Alternatively, PARP could have an indirect role in the process of fork 
reversal by regulating chromatin modifications and structure around replication forks 
(Hassa and Hottiger, 2008). It has been recently shown that PARP is involved in the 
modification of histone tails (Messner et al., 2010) thus implicating its role in 
nucleosome dynamics. Another indirect role of PARP in fork reversal would be imply 
the recruitment of other factors to the replication forks, which could in turn mediate 
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fork reversal upon Top1 inhibition and possibly other types of replication stress. 
Recent collaborative work with the group of Alessandro Vindigni (ICGEB, Trieste, 
Italy) suggests that PARP could be involved in the recruitment of proteins of the 
RecQ helicase family (particularly RecQ1), which in turn could possibly mediate fork 
reversal upon treatment with CPT. We are actively working on this exciting 
hypothesis, although the data are at this stage too preliminary to be included in this 
thesis. Further work will be required to identify additional cellular factors (possibly 
PARP targets) involved in this process and to clarify the molecular mechanism by 
which PARP mediates for reversal (see Perspectives). Besides impairing fork 
reversal, PARP inhibition also prevents CPT-induced fork slowdown (Sugimura et al, 
2008, Fig.2.17) and lead to increased amounts of DSBs at low (nM) CPT 
concentrations (Fig.2.20 and Fig.2.21) suggesting that PARP mediated fork reversal 
could prevent the formation of DSBs by limiting the impact of replication forks with 
unrepaired Top1cc. 
The CPT-induced slowdown and reversal of replication forks seem largely 
independent from checkpoint activation. Two lines of evidence supporting this 
conclusion are: 1) Fork slowdown is observed both in the presence (Fig.2.13) and 
absence (Fig.2.2A and Fig.2.5A) of checkpoint activation; 2) PARP inactivation 
abolishes CPT-induced fork slowdown (Fig.2.17) and reversal (Fig.2.18) while 
retaining an active checkpoint response (Fig2.19). Our attempts to study directly the 
role of the checkpoint response in slowing fork progression upon Top1 inhibition 
were overall inconclusive,  as, in agreement with published results (Peterman et al., 
2010), Chk1 inactivation resulted per se in severe fork progression defects, thus 
precluding to directly assess its contribution to CPT induced fork slowdown. 
Intriguingly, both ATR/Chk1 and ATM/Chk2 checkpoint pathways are promptly 
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activated at low CPT doses (25nM), associated with no detectable DNA breakage 
(Fig. 2.12A and Fig.2.13A). Moreover, in our experimental conditions, Chk1 
activation was also found to be independent of DNA end resection mediated by CtIP, 
further suggesting that structures different from DSB may contribute to the 
checkpoint response observed upon Top1 inhibition. An interesting hypothesis is that 
the regressed arm may itself represent a new "DNA end", presumably 
indistinguishable from a DSB for the checkpoint apparatus, but generated in the 
absence of chromosomal breakage and/or classical DSB processing. While such a 
double stranded end may per se be recognized by the ATM checkpoint machinery, 
further resection of the double stranded end or partial uncoupling of leading and 
lagging strand at the time of fork reversal may lead to single stranded overhangs 
capable of activating also the ATR checkpoint response (Fig.3.1).  The cellular 
response elicited by these alternative structures may well vary in different systems, 
reflecting different thresholds and mechanisms of checkpoint activation: similar DNA 
intermediates (reversed forks) may indeed be signaling structures in mammalian cells, 
but be unable to activate a DNA damage checkpoint in yeast cells (Redon et al., 2003, 
Fig.2.5 and Fig.2.14D). Importantly, under the same conditions, a general DNA 
damage marker, like H2A phosphorylation, is promptly activated in yeast cells 
(Redon et al., 2003). Furthermore, even in mammalian cells, treatment with low 
concentrations of CPT induces γH2AX foci, but these do not colocalize with the DSB 
marker 53BP1 (Fig.2.21). Overall these data suggest that several markers previously 
used to diagnose CPT-induced DSB may in fact identify different structures (e.g. the 
regressed arms).  
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 Fig.3.1 Hypothetical model for the contribution of regressed arms to checkpoint activation upon 
Top1 inhibition. Reversal of forks with proper coupling of leading and lagging strand synthesis 
(normal forks) results in ds ("blunt")-regressed arms; these could be recognized as DSB and activate 
per se the DNA damage checkpoint, even in the absence of chromosomal breakage. Further processing 
(resection) of the ds-end may also contribute to checkpoint activation. Fork reversal at a replication 
intermediate that is experiencing uncoupling of leading and lagging strand synthesis (uncoupled fork) 
may directly lead to ss-regressed arms and further contribute to checkpoint activation upon Top1 
inhibition. 
 
Replication forks were recently reported to slow down before impacting a DSB on the 
template (Doksani et al., 2009) or in short proximity to an inter-strand crosslink 
(Raschle et al., 2008). In both cases, active control of fork progression is proposed to 
assist effective repair and fork fusion at the lesion. Analogously, PARP1 could 
participate directly in the removal of trapped Top1 (Malanga and Althaus, 2004) and 
simultaneously provide more time for this reaction, by slowing/reversing active forks 
and preventing Top1cc conversion into DSB (Fig.3.2). It will be important to 
investigate whether fork reversal reflects a general strategy to protect the integrity of 
replicating chromosomes in face of different sources of replication stress and whether 
reversed forks can be reactivated for continued replication (see Perspectives). 
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Fig.3.2. Model for the mechanism of Top1 inhibition. Upon Top1 inhibition replication forks rapidly 
experience reduced progression and reversal, mediated by PARP activity in higher eukaryotes, 
assisting Top1cc repair and replication completion. PARP inactivation leads to increased DSB, due to 
unrestrained fork run-off at Top1cc. High CPT doses lead to incomplete replication and persistent fork 
stalling, causing DSB by eventual fork run-off and/or processing. 
 
In higher eukaryotes, checkpoint activation upon replication stress further assists 
replication completion by promoting local initiation events (Ge and Blow, 2010). 
Nonetheless, the extreme number of Top1cc upon acute (≥1μM) CPT treatments will 
continually stall all active replication forks (Fig.2.10A) and lead to DSB by eventual 
fork impact with unrepaired Top1cc by run off and/or stalled fork processing by 
endonucleases (Fig.3.2). However, these high CPT doses are lethal also to normal, 
untransformed cells (Teicher, 2008) and are not suitable for clinical use. Accordingly, 
genetic contributions to CPT resistance are consistently revealed in the low 
nanomolar range (O'Connell et al., 2010). While DSB are not detectable in these 
experimental conditions, a significant fraction of active replication forks (25-40%) is 
reversed in human and mouse cells, suggesting that reversed fork formation, 
remodeling and/or resolution may be more crucial determinants than DSB repair for 
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CPT resistance (see Perspectives). 
Overall, the data in this thesis provide a mechanistic rationale for the combination of 
PARP and Top1 inhibitors in cancer therapy, currently in promising clinical 
development. Indeed, minimal doses of Top1 inhibitors - insufficient per se to induce 
significant numbers of DSB - could result in more extensive chromosomal breakage 
when combined with PARP inhibitors. This synergistic effect could be particularly 
toxic in cancer cells, often defective in DNA repair and genome integrity pathways. 
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4. PERSPECTIVES 
 
In this thesis, it was shown that Top1 poisons rapidly induce replication fork slowing 
and reversal, which can be uncoupled from DSB formation at sub-lethal doses. Poly 
(ADP-ribose) polymerase (PARP) activity is required for effective fork reversal and 
limits DSB formation, making DSB processing dispensable for bulk DNA replication 
and checkpoint activation. These data have shown - for the first time in eukaryotic 
cells - that fork reversal could be used as cellular strategy to prevent chromosome 
breakage upon CPT induced replication stress and provide a mechanistic basis for the 
synergistic effects of PARP- and Top1 inhibitors. 
The identification of fork reversal as a strategy to prevent DSBs upon CPT treatment 
has opened new important biological questions and corresponding avenues of 
research. Some of the directions that will be investigated in the future are listed 
below. 
It would be important to analyze whether fork reversal represents a general strategy to 
protect replicating chromosomes in the face of both exogenous and endogenous 
lesions. Specific experiments will be designed to look at replication intermediates 
upon treatment with different kinds of DNA damages like interstrand crosslinking 
(induced by agents like mitomycin C and cisplatin), DNA polymerase inhibitor 
aphidicolin, etc. These experiments would initially be performed in Xenopus egg 
extracts as this provides an excellent platform for EM analysis due to the high 
frequency of replication intermediates, which speeds up this kind of analysis. Any 
encouraging result would then be further investigated in the mammalian cell culture 
system. It would also be important to investigate if fork reversal is also a mechanism 
to deal with endogenous lesions faced during replication, although this kind of 
analysis is potentially hampered by paucity of these events on the large eukaryotic 
genomes. PARP is activated after different kinds of DNA damage, but gets rapidly 
degraded after activation, which is mediated by PAR glycohydrolase (PARG). Since 
PARP is essential for fork reversal upon CPT treatment (this thesis), we hypothesize 
111
_____________________________________________________________
                              PERSPECTIVES
_____________________________
that, if fork reversal is a general mechanism used to face endogenous lesions, 
inhibition/depletion of PARG might stabilize PAR polymers and leading to 
accumulation of reversed forks even in the absence of exogenous damage. 
Experiments will be designed to test this hypothesis by the inhibition/depletion of 
PARG and analysis of replication intermediates by EM. Similarly, PARG inhibition 
may hamper restart of reversed forks once DNA damaging agents (Top1 inhibitors 
and/or others) are removed from the culture media. 
It will also be important to elucidate the role of different factors that contribute to 
form/revert/process reversed forks in response to CPT treatment.  Genetic defects in 
several members of the RecQ helicase family (WRN, BLM and RecQ1) are 
associated with increased sensitivity to CPT, suggesting a possible role in the fork 
reversal process. Furthermore, recent collaborative work with the group of Alessandro 
Vindigni (ICGEB, Trieste, Italy) has identified RecQ1 as an interacting partner and 
target of PARP1. Intriguingly, our preliminary collaborative data suggest that RecQ1 
depletion phenocopies PARP inhibition upon CPT treatment in terms of DSB 
formation and replication fork progression. EM experiments are thus being performed 
to test whether, upon CPT treatment, RecQ1 could be required for PARP-mediated 
fork reversal. Similar experiments will also be performed with WRN and BLM 
depleted cells to test their contributions to fork reversal, fork slowing and DSB 
formation upon CPT treatments. Another important candidate to test is the Fanconi 
Anemia group M protein (FANCM), a translocase of the FA family. It has been 
shown to promote reversal of replication fork structures in vitro (Gari et al., 2008)and 
has been proposed to sense and remodel stalled replication forks(Luke-Glaser et al., 
2010). Collaborative efforts have been planned to address this open question with the 
groups of Angelos Constantinou (CNRS, Montpellier, France) and Johan de Winter 
(Amsterdam, NL), focused on FANCM and other related replication stress factors. 
We will test the role of FANCM, analyzing MEFs from FANCM defective mice upon 
treatment with CPT and other DNA damaging drugs. 
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Finally, we are obviously interested in investigating the mechanism by which PARP 
could directly mediate fork reversal. As discussed earlier, PARP activation could 
restore DNA supercoiling and has also been shown to modify histone tails. We will 
start our investigations in this direction by testing whether any of the PARP-
dependent chromatin modifications is required for fork reversal upon CPT treatments. 
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5. MATERIALS AND METHODS 
 
Materials 
The antibodies used in this study were goat polyclonal anti-CtIP (Santa Cruz), rabbit 
monoclonal pATM-Ser1981 (Epitomics), rabbit monoclonal pChk1-Ser345 (Cell 
signalling), rabbit polyclonal TFIIH (Santa Cruz), mouse monoclonal anti-BrdU 
antibody 2B1 (MBL) and anti-PK SV5-Pk1 antibody (AbD Serotec), EL7 for total 
Rad53 and F9 for pRad53 (Bermejo et al., 2007), mouse monoclonal γH2AX 
(Millipore), rabbit polyclonal 53BP1 (Santa Cruz). The chemicals and peptides used 
in this study were: Camptothecin (Sigma); Topotecan Hydrochloride (Molekula); α1-
Mating Factor (Sigma); Nocodazole (Sigma); Thymidine (Sigma), Olaparib (Selleck 
Chemicals), NU1025 (Sigma), UCN-01 (Sigma). 
 
Cell growth, labeling and synchronization 
The S. cerevisiae strains used in this study are W303-1A and its isogenic derivative 
rad52D (CY2272). Strains were grown in YPD, presynchronized in G1 by adding 
3µg/ml α factor and released from the G1 arrest by addition of Pronase 200µg/ml in 
presence or absence of 50µM CPT at 25°C. For BrdU ChIP-chip experiments, strains 
and conditions were described (Bermejo et al., 2007; Katou et al., 2003). For these 
experiments, cells were released from α factor at 16°C, by media replacement with 
pre-cooled YPD in the presence of Pronase 200µg/ml. Rpc25 and Rpb3 subunit 
binding were analyzed by ChIP-chip 60min after release in presence of CPT or during 
unperturbed S-phase respectively.  
U2OS-derived cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS) and standard antibiotics. For 
114
_____________________________________________________________
          MATERIALS AND METHODS
_____________________________
synchronization, 50% confluent U2OS cells were treated with 2mM Thymidine for 
24h. The cells were then washed 3 times with PBS and released into fresh medium for 
3h. This was followed by nocodazole treatment for 12h (75ng/ml). The cells were 
again washed three times with PBS and incubated in fresh medium. At the indicated 
times, cells were trypsinized and processed for cell cycle analysis, western blots and 
PFGE. 
Primary MEFs PARP-1+/+ (F20) and PARP-1−/− (A1) (Wang et al., 1995) were 
maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 
10% fetal bovine serum, 100 U/ml penicillin, and 100 µg/ml streptomycin in an 
atmosphere containing 10% CO2 at 37 °C. 
 
siRNA depletions in mammalian cells 
U2OS cells were transfected with relevant siRNA using Oligofectamine (Invitrogen) 
according to the manufacturer's instructions. The cells were then incubated for 48-72 
hrs. The mRNA target sequences used for siRNAs were the following: siLuciferase 
(CGUACGCGGAAUACUUCGA), siCtIP (GCUAAAACAGGAACGAAUCUUTT) 
 
ChIP-chip analysis 
S.cerevisiae oligonucleotide microarrays were provided by Affymetrix (S.cerevisiae 
Tiling 1.0R, P/N 900645). BrdU ChIP-chip analyses were carried out as described 
(Katou et al., 2003), using similar statistical parameters for peak identification. 
Orange (untreated, NT) and blue (CPT) histogram bars in the Y-axis show the 
average signal ratio of loci significantly enriched in the BrdU-immunoprecipitated 
fraction (IP) along the indicated regions in log2 scale (detection p-value and change 
p-value are <0.001). Merging of the BrdU peaks +/- CPT is also shown in green. The 
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X-axis shows chromosomal coordinates. ARS elements are indicated, green lines 
indicate centromeres and the blue horizontal bars mark the position of the ORFs. 
CPT-induced replication fork delay and association with specific chromosomal 
features (CEN, TERs) were scored as described in the legends of Fig.2.1, Fig.2.2and 
Table 2.1.  
  
Cell Cycle Analysis, Protein Extraction and Western Blotting 
The procedures for yeast protein extraction, Western blotting, and FACS analysis 
were already described (Pellicioli et al., 1999). U2OS cells were processed for FACS 
analysis as described (Stojic et al., 2004). Mammalian cell extracts were prepared in 
Laemmli buffer (4% SDS, 20% glycerol, 120 mM Tris-HCl pH 6.8), proteins were 
resolved by SDS-PAGE and transferred to nitrocellulose. Immunoblots were 
performed using the appropriate antibodies. 
 
Mammalian fork progression by DNA fibre analysis 
Asynchronously growing U2OS cells were labelled with 30µM CldU, washed with 
PBS and exposed to 250µM IdU. Cells were lysed and DNA fibres were stretched 
onto glass slides as reported earlier (Jackson and Pombo, 1998) The DNA fibres were 
denatured with 2.5M HCl for 1 h, washed with PBS and blocked with 2% BSA in 
PBST for 30 min. The newly replicated CldU and IdU tracks were revealed with anti-
BrdU antibodies recognizing CldU (Abcam, rat) and IdU (Becton Dickinson, mouse), 
respectively. The following secondary antibodies were used: anti-mouse Alexa 488 
(Molecular Probes), anti-rat Cy3 (Jackson Immunoresearch). Microscopy was carried 
out with an Olympus IX81 fluorescence microscope and acquired with a CCD camera 
(Orca AG, Hamamatsu). The images were processed with CellR software (Olympus). 
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Statistical analysis of tract length was performed using GraphPad Prism.  
 
DSB detection by PFGE 
DSB detection by PFGE was performed as described (Hanada et al., 2007), with 
minor modifications. Synchronous or asynchronous subconfluent cultures of U2OS 
cells were harvested by trypsinization, and agarose plugs of 5x105 cells were prepared 
in a disposable plug mold (BioRad). Plugs were then incubated in lysis buffer 
(100mM EDTA, 1% (w/v) sodium lauryl sarcosyl, 0.2% (w/v) sodium deoxycholate, 
1mg/ml proteinase K) at 37°C for 72h. Plugs were then washed four times in 20mM 
Tris-HCl pH 8.0, 50mM EDTA before loading onto an agarose gel. Electrophoresis 
was performed for 23h at 14°C in 0.9% (w/v) Pulse Field Certified Agarose (BioRad) 
containing Tris-borate/EDTA 1X buffer in a BioRad CHEF DR III apparatus, 
according to the following protocol (Block I: 9h, 120° included angle, 5.5 V/cm, 30- 
18s switch; Block II: 6h, 117° included angle, 4.5 V/cm, 18-9s switch; Block III: 6h, 
112° included angle, 4.0 V/cm, 9-5s switch). The gel was then stained with ethidium 
bromide and analyzed using an Alpha Innotech Imaging system. DSB quantification 
was performed by the ImageJ software, normalizing DSB signals to unsaturated 
signals of DNA trapped in the well (loading control). For each treatment, relative 
DSB levels were obtained comparing each treatment to the background DSB signals 
observed in untreated (NT) conditions. Average values and standard deviations were 
obtained from three biological replicates of the same experiment. 
 
Xenopus egg extracts and replication assays 
Interphase egg extracts were prepared as described (Trenz et al., 2006). DNA 
replication assay with neutral (Trenz et al., 2006) and alkaline agarose gels (Fukui et 
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al., 2004) were previously described.  The fork restart assay (Fig2.16) was performed 
as follows. After the first incubation of sperm nuclei in the presence of 100µM TPT, 
the extract sample (40µl) was first diluted with 10 vol. of EB-buffer (100mM KCl, 
50mM Hepes-KOH [pH 7.5], 2.5mM MgCl2) + 0.005 % Triton X-100, layered onto 
200µl of EB-buffer + 30% Sucrose, and spun at 10,000g for 5 min at 4°C. The pellet 
was resuspended with 20µl of the buffer (50mM Tris-HCl [pH 7.5], 50mM KCl, 
10mM MgCl2, 0.5mM DTT, 0.1mM EDTA, 30µg/ml BSA) in the presence or 
absence of 6 units of purified calf thymus Topoisomerase I (Invitrogen). After 30 min 
incubation at 37°C, 300µl of the EB-buffer was added to the reaction, which was 
subsequently spun at 10,000g for 2 min at 4°C. The pellet was resuspended with 40µl 
of the 2nd extract - containing a-32P-dATP, His-geminin (320nM), His-p27 
(40µg/ml) and TPT (100µM) - incubated for the indicated times and subjected to 
DNA replication assay. 
 
EM analysis of genomic DNA in yeast, mammalian cells and Xenopus egg 
extracts 
In vivo psoralen cross-linking, isolation of total genomic DNA, and enrichment of the 
RIs from yeast and mammalian cells were performed as described (Lopes, 2009). For 
Xenopus egg extracts demembranated sperm nuclei (5,000/µl) were incubated in 1.2-
1.5 ml of egg extracts for 50 min in presence or absence of 50µM TPT, diluted with 
5ml of EB-buffer, layered onto 2ml of EB-buffer + 30% Sucrose and spun at 3,000g 
for 10 min at 4℃. The pellets were re-suspended in 600µl of EB-buffer and 
transferred to a 96 well plate (each 100µl/well). Trimethylpsoralen (TMP) was added 
at 10µg/ml to each well. Samples were incubated on ice for 5 min in the dark, 
irradiated with 366nm UV light for 7 min on a pre-cooled metal block. The procedure 
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from TMP addition to UV irradiation was repeated three more times. Then, the 
genomic DNA was purified by proteinase K (1mg/ml) and RNase A (167µg/ml) 
treatment, phenol/chloroform extraction, and isopropanol precipitation. The purified 
DNA (20µg) was digested with NdeI endonuclease (100 units) for 5 hr, and the 
replication intermediates were further purified on BND cellulose column and 
processed for EM observation as previously described (Lopes 2009). 
 
Agarose bi-dimensional gel electrophoresis (2D gel) 
Total genomic DNA was extracted by the CTAB method (Lopes et al., 2003) and 
used for 2D gel electrophoresis, as originally described (Brewer and Fangman, 1987). 
First dimensions were run at RT for 16 hr at 50 V in 0.4% agarose gels in 1X TBE. 
Second dimensions were run at 4°C for 9 hr at 140 V in 1.0% gels in 1X TBE + 
0.3µg/ml EtBr recirculating buffer. Restriction fragments, probes, and hybridization 
conditions were as described (Lopes et al., 2003), except that DNA was here blotted 
onto BIORAD Zeta-Probe GT membranes prior to hybridization. 
 
Immunofluorescence staining and analyses 
For immunostaining, cells were fixed in methanol, stained with 53BP1 (sc-22760, 
Santa Cruz 1/500) and γH2AX (05-636, Upstate; 1/500), detected by appropriate 
secondary antibodies (Molecular Probes) and mounted with vectashield (Vector 
Laboratories). Cells were imaged in a Leica DM RB microscope equipped with a 
Leica DFC 360 FX camera. Images were taken at 60x magnification using the Leica 
Application Suite 3.3.0 software.  
Foci counting was performed by ImageJ, using the "Analyze particle" function. 
Average values for foci number and γH2AX/53BP1 colocalization were obtained 
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from at least 50 cells per sample. Very similar numbers to those shown in Figure 2.21 
have been obtained by an independent experiment. 
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